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 Transcriptional control imparted by nuclear receptor co-repressor (N-CoR) 
plays an important role in the growth suppressive function of several tumour 
suppressor proteins. Abrogation of this transcriptional control due to a misfolded 
conformation dependent loss (MCDL) of N-CoR has been implicated in acute 
promyelocytic leukemia (APL). It was hypothesized that an APL like MCDL of N-
CoR might be involved in other malignancy. Indeed, the initial screening of N-CoR 
status in various liver cancer (HCC) cell lines revealed an APL like MCDL of N-CoR 
protein. The N-CoR protein presented in these HCC cells was misfolded and was 
linked to the amplification of endoplasmic reticulum (ER) stress and cytoprotective 
unfolded protein response (UPR). siRNA-induced N-CoR ablation led to selective 
reduction of intracellular ATP level and significantly compromised the growth of 
HCC cells, suggesting an important role of energy, possibly derived from N-CoR 
catabolism, in HCC cell growth. These findings identify an important role of 
autophagy-induced recycling of misfolded N-CoR protein in the selective activation 
of autonomous survival and growth in HCC cells. 
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Chapter 1. Introduction 
1.1 Liver Cancer 
 Liver cancer is one of the most lethal malignancies worldwide. Globally it 
ranks the second most frequent cause of cancer death in men and the sixth in women 
(Ahmedin et al., 2011). Liver cancer consists of several histologically different 
primary hepatic malignancies, such as cholangiocarcinoma (bile duct cancer), 
hepatoblastoma (liver cancer affecting young children) and haemangiosarcoma 
(cancer arising from the blood vessels of the liver). Hepatocellular carcinoma (HCC), 
also called malignant hepatoma, is by far the most common type. 
1.2 Hepatocellular Carcinoma (HCC) 
1.2.1 Epidemiology 
 Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality 
in human. It is the fifth most common cancer worldwide, and the third leading cause 
of cancer-related deaths (Ferlay et al., 2008) with an estimate of one million deaths 
annually (Bosch et al., 2004; Cha and Dematteo, 2005).  
 The incidence of liver cancer varies around the world and is highest in 
Mongolia with 116.6 cases per 100,000 person-years for men; 74.8 cases per 100,000 
person-years for women (Ferlay et al., 2008). Over 80% of HCC cases occur in 
developing countries such as sub-Saharan Africa, Southeast Asia, and East Asia 
(including Mongolia). In contrast, the incidence of HCC is much lower in developed 
countries such as North America with 6.8 cases per 100,000 person-years for men; 2.2 





 In Singapore, HCC is the fourth most frequently occurring cancer in men with 
an overall incidence of 18.9 per 100 000 person-year (Singapore Cancer Society). The 
incidence is highest in the Chinese population as compared to the other ethnic groups 
(Yuen et al., 2009). 
1.2.2 Aetiological factors of HCC 
 Significant differences in HCC incidence across different countries reflect 
regional differences in the prevalence of specific aetiological factors. The most 
prominent factors associated with an increased risk of HCC include chronic hepatitis 
B and C viral infection, aflatoxin B1 contamination and severe alcohol abuse. Other 
aetiological factors which occurred at a lower frequency include demographic 
characteristics (gender and age), lifestyle (smoking) and clinical factors (metabolic 
abnormalities, diabetes, and obesity).  
 Overall, viral infection has been indexed as the major risk factor because more 
than 80% of HCC in humans are attributable to infection with either hepatitis B or C 
virus or both (Parkin et al., 2006). Nevertheless, it should be highlighted that the risk 
of HCC increases in the event of multiple risk factors. 
1.2.2.1 Hepatitis B virus (HBV) 
 Hepatitis B virus (HBV) is a 3.2kb partially double stranded DNA virus that 
can elicit an acute and chronic inflammatory response in the liver. It infects 
approximately 2 billion individuals globally and causes an estimated 320 000 deaths 
annually (Lavanchy, 2004). As such, HBV-associated HCC is a disease of global 
importance and is ranked the top 5 most frequent cancers worldwide (Marrero, 2006). 





 An array of processes is involved in HBV-induced hepatocarcinogenesis. 
These include host-viral interactions (Block et al., 2003; Nowak et al., 1996; Wieland 
et al., 2004; Rehermann et al., 2004), sustained cycles of necrosis-inflammation-
regeneration (Block et al., 2003; Lok et al., 2001), viral-endoplasmic reticulum 
interactions (Kojima, 1982), viral integration into the host genome (Brechot, 2004) 
and targeted activation of oncogenic pathways by viral proteins (Matsubara et al., 
1990).  
 The 16.5 kDa HBV X protein (HBX) is suspected to be an important 
oncogenic factor in hepatocarcinogenesis (David et al., 2006). In vivo studies have 
shown that it can trans-activate a large number of promoters related to inflammation 
and cell proliferation through protein-protein binding. This mechanism allows HBX 
to undergo favourable alteration in the cellular environment for further viral 
replication (Tang et al., 2006). In the infected liver host cells, HBX appears to induce 
variety of responses such as genotoxic stress response, transcription modulation, 
protein degradation, cellular signalling pathways, cell cycle checkpoints and apoptosis 
(Murakami, 2001). HBX has since been proposed to be strongly related to the 
progression of HCC however its exact role in malignant transformation has yet to be 
fully elucidated.  
1.2.2.2 Hepatitis C virus (HCV) 
 Hepatitis C virus (HCV) is a 9.6kb non-cytopathic virus of the flaviviridae 
family. It possesses a positive single-stranded RNA genome encoding non structural 
proteins (NS2, NS3, NS4A, NS5A and NS5B) and structural proteins (core, E1, E2). 
HCV has been implicated to be responsible for an estimate of 170 million chronic 





(McGlynn and London, 2005), predominantly in developed nations such as Europe, 
United States and Japan (Bosch et al., 1999) 
 Analogous to HBV infection, HCV induces liver inflammation followed by a 
continuous cycle of hepatocyte cell death and regeneration. However, unlike HBV, its 
genome is RNA-based, thus it is unable to integrate to host genome to induce 
hepatocarcinogenesis (Rehermann et al., 2005). Instead, HCV has been shown to 
possess the   propensity   to   evade   the   host’s   immune response to promote 
tumourigenesis (Gale and Foy, 2005). The HCV’s  RNA and core proteins are found 
to impair dendritic functions which are important for T-cell activation (Pachiadakis et 
al., 2005) and evade immune-mediated cell death by interacting with interferon-α  and  
tumour necrosis factor-α  (Melén et al., 2004; Gale and Foy, 2005). Additional roles of 
the HCV core proteins in the pathogenesis of HCC include inhibition of apoptosis 
(Kamegaya et al., 2005), interference with cell signalling pathways to modulate cell 
proliferation (Hino O. et al., 2002; Macdonalds et al., 2003) and modulate p53 
transcription thereby affecting the p53-regulated pathways (Majumder et al., 2001). In 
mouse models, HCV core proteins have been shown to induce hepatic steatosis as 
well as reactive oxygen species (ROS) and oxidative stress (Moriya et al., 1998; 
2001). These data collectively suggest that viral proteins play a direct role in inducing 
hepatocarcinogenesis.  
1.2.2.3 Aflatoxin B1 (AFB1) 
 Aflatoxin B1 (AFB1) is a mycotoxin that is produced by the Aspergillus fungi. 
Epidemiological studies have shown that AFB1 consumption increases HCC risk by 
approximately four-fold. Further, it has been observed that areas of high HCC 





(Groopman et al., 1996; Qian et al., 1994). Previous studies have also shown that the 
combination of AFB1 and HBV is likely to increase the risk of HCC by 60-fold (El-
Serag and Ruldolph, 2007; McGlynn and London, 2005). 
 Once ingested, AFB1 is metabolized to form a pro-mutagenic DNA adduct 
which results in a specific point mutation from guanine to thymine at codon 249 
(AGG to AGT) in the tumour suppressor, p53 (Moradpour and Blum, 2005; Wild and 
Montesano, 2009). To some extent, the loss of p53 function via mutation is believed 
to induce loss of cell growth control and eventually promote hepatocarcinogenesis. 
Further, this loss of p53 function has also been reported to assist the mutational 
activation of oncogenes such as human Harvey-ras proto-oncogene (HRAS) (Riley et 
al., 1997). Together, the mutational actions of AFB1 may contribute to the 
development of HCC. 
1.2.2.4 Alcohol 
 Chronic alcohol intake has long been recognized as an important HCC risk 
factor. Epidemiology data suggests that alcohol has been found to be a more 
prominent risk factor for HCC in low incidence areas than in high incidence areas. 
This may be due to the lower mean alcohol consumption and/or the dominant effect of 
HBV infection in the high-risk population (El-Serag and Ruldolph, 2007; Bosch et al., 
2005; McGlynn and London, 2005).  
 Alcohol-induced hepatocarcinogenesis has been associated with the 
production of inflammatory cytokines through monocytic activation (McClain et al., 
2002). Consequently, Kupffer cells are activated with the eventual release of 
chemokines and cytokines, leading to hepatocytes necrosis. Alcohol also damages the 





fibrosis and cirrhosis and creates a conducive HCC microenvironment (Campbell et 
al., 2005). Second, oxidative stress may decrease STAT1-directed  activation  of  IFNγ  
with consequent hepatocyte damage and constant tissue destruction ultimately leads to 
hepatocarcinogenesis (Osna et al., 2005).   
 1.2.3 Diagnosis and treatment 
 HCC patients are commonly diagnosed at very late stages due to the 
asymptomatic features during the course of neoplastic development and the lack of 
reliable biomarkers. Thus, this disease has a very poor prognosis with more than 50% 
of the patients dying within 1 year and less than 6% with a 5 year survival rate 
(Hoofnagle, 2004). 
1.2.3.1 Screening tests 
 The most widely used marker today for HCC is alpha-fetoprotein (AFP). In 
recent years, clinical research has discovered a fucosylated AFP (AFP-L3) to be a 
new tumour marker with sensitivity of about 56% and specificity of >95% (Li et al., 
2001). More importantly, it has been suggested to be a specific indicator for poorly-
differentiated and unfavourable diagnosis (Tateishi et al., 2006). 
 Another established serum biomarker for HCC is an abnormal prothrombin, 
des-gamma-carboxy prothrombin (DCP) (Liebman, 1989; Aoyagi et al., 1996). DCP 
has been reported to be the most significant predisposing factor for the development 
of portal vein invasion which is an indicator of end-stage liver disease (Koike et al., 
2001). Hence, it is more commonly used as a diagnostic marker rather than for 
surveillance. Together, DCP may complement AFP or AFP-L3 for HCC diagnosis 





al., 2000; Marrero et al., 2005), glypican-3 (Nakatsura et al., 2003; Capurro et al., 
2003), hepatocyte-growth factor (Yamagamim et al., 2002), insulin growth factor 1 
(Mazziotti et al., 2002), vascular endothelial growth factor (Poon et al., 2004; 
Schoenleber et al., 2009) and transforming growth  factor  β-1 (Song et al., 2002; Yao 
et al., 2007). 
 Other than biomarkers, imaging studies play a crucial role in the diagnosis of 
HCC. Imaging techniques most commonly used for the diagnosis of HCC include 
ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), 
and angiography. While ultrasonography is widely accepted for HCC surveillance, 
spiral computed tomography (CT) or dynamic magnetic resonance imaging are the 
required imaging techniques for diagnostic confirmation and intrahepatic tumor 
staging. Currently, with the development of imaging modalities, invasive biopsy is 
infrequently required prior to treatment, and the diagnosis of HCC is strongly 
dependent on hemodynamic features (arterial hypervascularity and washout in the 
venous phase) on dynamic imaging. 
1.2.3.2 Treatment 
 To date, the only proven cures for HCC are surgical resection or liver 
transplantation. However, for liver transplantation, the scarcity of donor liver remains 
a universal problem. In addition, a major concern for resected HCC patients is the 
possibility of recurrence that can occur in about 75% of the resected patients (Llovet 
and Bruix, 1999).       
 In cases when HCC lesions are unresectable, an alternative option is non-
surgical treatment. For example, radiofrequency ablation (RFA) uses a needle with an 





scanning. The local heat generated then melts the tumour tissues (Gough-Palmer and 
Gedroyc, 2008). Other treatments include conventional or molecular targeted 
chemotherapy and radiotherapy. 
1.2.4 Challenges in understanding HCC 
 Hepatocarcinogenesis is a multistep process involving diverse aetiologies, 
ranging from metabolic disorders to hepatoxins to viruses. As documented by 
numerous independent HCC studies, the genetic aberrations in HCCs are 
heterogenous whereby distinct molecular players but related genetic pathways are 
affected (Thorgeirsson et al., 2006).  Nevertheless, the exact underlying mechanism 
of hepatocarcinogenesis remains elusive. To aggravate the situation, early 
hepatocellular carcinoma is characteristically silent and slow growing with few 
symptoms until late in disease. The lack of clinically validated biomarkers and 
clinical identification of hepatocellular carcinoma at advanced stages present 
difficulties for diagnosis and treatment. While advances in computed tomography and 
magnetic resonance imaging have markedly increased the sensitivity and specificity 
of testing, they are still flawed with a relatively high false-positive rate. Several 
surgical and nonsurgical therapies have been developed, but used with varying 
degrees of success.  
 Hepatocellular carcinoma in general is a disease of multifactorial etiology and 
confers many management challenges. It is therefore imperative to identify and 
characterize new molecular mechanisms associated to HCC. This allows a better 






1.3 Acute promyelocytic leukemia (APL) 
 Acute promyelocytic leukemia (APL), designated as AML-M3 (acute myeloid 
leukemia) in FAB (French American and British) classification (Bennett et al., 1976), 
is a disease characterized by the chromosomal translocation involving retinoic acid 
receptor-alpha   (RARα)   gene   on   chromosome   17   with   the   promyelocytic   leukemia  
gene (PML) on chromosome 15. It represents about 10% of all AML in adults with a 
lower incidence reported in children (Stone et al., 1990; Chan et al., 1981). 
1.3.1 PML-RARα 
 The ramification of chromosomal translocation mentioned earlier is the 
generation of a fusion oncoprotein PML-RARα. Since its discovery in the 1990s, the 
transformation role of PML-RARα  in  APL  has  been  well studied. One direct evidence 
shown in two studies is the generation of an APL-like disease when this fusion protein 
was targeted to the myelocytic compartment in transgenic mice (He et al., 1997; 
Grisolano et al., 1997). Studies have elucidated the role of PML-RARα  as  a  dominant  
negative transcription repressor. PML-RARα  has  been  proposed  to  recruit  the  N-CoR 
containing chromatin-remodeling complex to their promoters which eventually 
repress the target genes for differentiation of granulocytes (Lin et al., 1998; Grignani 
et al., 1998). It also recruits methylating enzymes and hypermethylates promoters of 
retionic acid (RA) target genes resulting in transcriptional repression. The overall 
outcome of this PML-RARα-induced transcriptional inhibition is differentiation arrest 







1.3.2 Nuclear hormone co repressor (N-CoR) 
 N-CoR is a key component of the co-repressor complex involved in 
transcriptional control. It was originally identified as a co-repressor of un-liganded 
nuclear hormone receptors such as thyroid-hormone and retinoic acid (Heinzel et al., 
1997; Laherty et al., 1997). Later, it was shown to interact with different co-
repressors and histone deacetylase complexes (HDACs) to mediate repression by 
steroid hormone receptors as well as by tumour suppressor Mad to suppress 
proliferation (Khan et al., 2001). 
1.3.3 Current knowledge of PML-RARα,  N-CoR and its perceived mechanism 
 in APL 
 
 It has now been recognized that N-CoR recruitment by PML-RARα 
contributes to transformation of APL cells by repressing retinoic acid (RA) target 
genes essential for the maturation of promyelocytic cells (Lin et al., 1998; Grignani et 
al., 1998). Nevertheless, this may not be the only mechanism behind APL 
pathogenesis. It has been proposed recently that PML-RARα could also abrogate N-
CoR-mediated repressor pathway.  
 In APL cells, two distinct forms of N-CoR protein existed, the natively folded 
and stable N-CoR localized in the nucleus, and the misfolded and unstable N-CoR 
found in the cytosol (Ng et al., 2006). Similar to N-CoR, at least two distinct forms of 
PML-RARα protein, nuclear and cytosolic, are observed in most APL-derived cells. It 
was thus hypothesized that each form of PML-RARα engages the respective form of 
N-CoR protein to regulate two opposing transcriptional mechanisms that ultimately 
leads to derailment of both the activation and repression pathway in a synchronized 





natively folded N-CoR on the RA promoter and turn off the expression of the RA-
regulated genes. Simultaneously, the cytosolic form of PML-RARα/N-CoR complex 
leads to de-repression of self-renewal genes (Fig 1.1). The combined outcome of 
concurrent deregulation of these two pathways leads to ectopic re-activation of self-






Figure 1.1. Model of bifunctional role of nuclear receptor corepressor in acute 
         promyelocytic leukemia pathogenesis 
 
 
Two distinct forms of PML-RAR, one nuclear another cytosolic, could engage the N-
CoR protein in a bifunctional manner, which would have two opposing transcriptional 
outcomes. The nuclear PML-RAR could repress the RA target genes by recruiting the 
natively folded and fully functional N-CoR to the RA promoter, while the self-
renewal genes originally repressed by N-CoR could be de-repressed owing to PML-







1.4 ER stress and unfolded protein response (UPR) 
1.4.1 Protein folding 
 Protein folding occurs in a specialized compartment- the endoplasmic 
reticulum (ER). The ER is an oxidising environment that contains high amounts of 
ATP and Ca2+ required for its proper function (Gaut et al., 1997). In the ER, only 
correctly folded molecules can proceed further into the secretory pathway and that 
persistently misfolded proteins are targeted for degradation. 
 Three classes of proteins in the ER assist nascent proteins to fold properly – 
molecular chaperones like glucose-regulated proteins (GRPs) GRP78, GRP94 and 
lectin-like proteins, folding enzymes like protein disulpide isomerase (PDI) and ER-
degradation-enhancing  α-mannosidase-like protein (EDEM) (Schroder et al., 2005).  
 One of the most abundant proteins in the ER is binding Ig protein (BiP) 
BiP/GRP78- a member of the heat shock protein (Hsp)70 family of chaperones 
(Mayer et. al., 1998) that transiently binds a wide variety of newly synthesized 
secretory proteins but associates more permanently with misfolded or unassembled 
proteins. The association and dissociation of peptides to BiP/GRP78 are thought to be 
coupled to the binding and hydrolysis of ATP (Flynn G.C. et al., 1999). The binding 
of peptides to BiP/GRP78, an ATP-dependent conformational change strengthens the 
interaction between GRP78 and the unfolded/misfolded protein. Under this condition, 
protein disulphide isomerase (PDI) can also work to promote disulfide reduction, 
rearrangement, and re-oxidation until the correct protein conformation is achieved. 
Once the protein conformation is corrected, refolded proteins will dissociate from 





 Partially folded monoglucosylated N-linked glycans are bound to lectin like 
proteins - calnexin (transmembrane ER protein) and calreticulin (soluble luminal ER 
protein) (Bergeron et al., 1998). Glucosidase II then removes the glucose residue on 
the oligosaccharide and releases the bound glycoprotein. If the glycoprotein remains 
unfolded, it is re-glucosylated by UDP-glucose:glycoprotein glucosyltransferase 
(UGGT) for interaction with the lectin like proteins. Numerous cycles of binding to 
and release from calnexin and calreticulin alternates until the protein is correctly 
folded or is sentenced for degradation by EDEM by removing its mannose residue 
(Ellgaard et al., 2003).  
 GRP94, another abundant chaperone protein has been reported to bind 
partially folded proteins that are unfolded by GRP78 or calnexin/calreticulin and 
retaining them in the ER (Argon et al., 1999). On the other hand, PDI interacts with 
the underperforming proteins for retrograde transport into the cytosol for ER-
associated protein degradation (ERAD) via the proteasome (Gillece et al., 1999).  
 In brief, misfolded proteins loiter in the ER for re-folding; otherwise, they are 
translocated in a retrograde manner back to the cytosol and targeted to proteasomal 
degradation by the 26S proteasome (Ellgaard et al., 1999; Brodsky et al., 1999).    
1.4.2 Unfolded protein response 
 ER stress occurs when the processing capacity of the ER is overwhelmed. The 
normal physiological state of the ER is thus perturbed. Unfolded protein response 
(UPR) is then activated in response to restore a favourable physiological state.  
 UPR involves three main signalling pathways: the activating transcription 





double-stranded RNA-activated protein kinase (PKR)-like endoplasmic reticulum 
kinase (PERK) pathway.  
 UPR is initiated when GRP78 dissociates from the intracellular receptors and 
binds preferentially to the misfolded proteins (Bertolotti et al., 2000). Upon sensing 
ER stress, PERK, a type I transmembrane kinase dissociates from GRP78 and 
activates itself through dimerization and autophosphorylation (Liu et al., 2000). Once 
activated, PERK phosphorylates elongation factor 2α (eIF2α),  which  transiently  slows  
down the rate of protein translation and attenuates protein synthesis (Harding et al., 
1999; Shi et al., 1998). Simultaneously,  phosphorylated  eIF2α  preferentially  initiates  
the translation of ATF4 mRNA, which contains an open reading frame within its 5’  
untranslated region. ATF4 then translocates into the nucleus and up-regulates ER 
stress target genes including amino acid transporters and cellular redox control genes 
(Zhang et al., 2004). More importantly, ER stress will be relieved as ATF4 activation 
induces the expression of C/EBP homologous protein (CHOP) leading to growth 
arrest and apoptosis (Ma et al., 2002).  
 Similar to PERK, IRE1 dissociates from GRP78, homodimerizes and 
transphosphorylates (Shamu and Walter, 1996; Welihinda et al., 1996) and triggers its 
endo-ribonuclease activity. Its cytosolic activated RNase domain then catalyses the 
splicing of 26-nucleotide intron sequence from X-box DNA-binding protein 1 (XBP1) 
mRNA (Sidrauski and Walter, 1997). This resulting XBP1 is a potent activator of 
UPR related genes which will migrate to the nucleus and bind upstream DNA UPR 
element (UPRE) or ER stress element (ERSE) (Lee et al., 2003; Yoshida et al., 1998). 
The UPR genes regulating XBP1 are essential for protein folding, maturation and 





 Finally, ATF6, a type II transmembrane protein, upon dissociation from 
GRP78, is translocated from the ER to the Golgi (Chen et al., 2002; Shen et al., 
2002). The 50 kDa cytosolic region of ATF6 is then proteolytically cleaved by site-1 
protease (S1P) and site-2 protease (S2P) (Shen, 2004). This active cytosolic ATF6 
domain then migrates to the nucleus to promote the transcription of ER-resident 
molecular chaperones and other assistant folding enzymes (Wang et al., 2000; 
Yoshida et al., 1998). ATF6 may also work in tandem with XBP1 to promote proteins 
needed to assist in the folding of unfolded proteins in the ER (Keisuke et al., 2003). 
 Another function of the UPR that does not involve any signalling pathway is 
the degradation of accumulated misfolded proteins to alleviate ER stress as well as to 
supply nutrients to the cell. This function is achieved by two main pathways. The first 
is ER-associated protein degradation (ERAD) of misfolded proteins which fail to be 
refolded, via the ubiquitin proteasome pathway (UPP). The second is autophagy, an 
alternative non-proteasomal degradation system that has recently been shown to be 
triggered by ER stress, to remove and recycle misfolded proteins. (Kawakami et al., 
2009; Yorimitsu et al., 2006). These two pathways will be further discussed in the 
following sections. 
 
1.4.3 UPR-induced apoptosis 
 Signalling may switch from pro-survival to pro-apoptotic in conditions of 
prolonged and severe ER stress. Given the central role of PERK, IRE1 and ATF6 in 
UPR signalling, it has been suggested that these UPR mediators may be fundamental 







Figure 1.2. UPR signalling pathways in mammalian cells 
The UPR is mediated by three ER resident transmembrane proteins that sense ER 
stress and signal downstream pathways. The PERK kinase is activated by 
dimerization and phosphorylation. Once activated, it phosphorylates eIF2α, resulting 
in translation attenuation. Phosphorylated eIF2α selectively enhances translation of 
the ATF4 transcription factor that induces expression of UPR target genes. Activation 
of IRE1 by dimerization and phosphorylation causes IRE1 mediated splicing of XBP1 
mRNA. Translation of spliced XBP1 mRNA produces a transcription factor that 
upregulates target genes via the ERSE promoter. ATF6 activation involves regulated 
intramembrane proteolysis. The protein translocates from the ER to the Golgi where it 
is proteolytically processed to release a 50 KDa transcription factor that translocates 
to the nucleus and binds the ERSEs of UPR target genes. All three ER resident 
transmembrane proteins are thought to sense ER stress through Grp78 binding/release 
via their respective luminal domains, although structural studies have also suggested 
that IRE1 may interact with infolded proteins directly. The GADD34 protein, a 
protein phosphatase up-regulated by the PERK pathway, dephosphorylates eIF2α to 





 In response to ER stress, IRE1 has been found to recruit the adaptor protein 
TNF receptor-associated factor 2 (TRAF2) to the ER membrane (Urano et al., 2000).  
The IRE1-TRAF2 complex then recruits the apoptosis-signal-regulating kinase 1 
(ASK1), which in turn phosphorylates and activates c-Jun N-terminal kinase (JNK) 
(Nishitoh et al., 1998). Activated JNK inactivates anti-apoptotic BCL2 through 
phosphorylation, thus causing it to malfunction in sequestering pro-apoptotic 
molecules and control Ca2+ influx (Bassik et al., 2004). JNK also phosphorylates BH-
3, releasing them from inhibition thus allowing them to exert their pro-apoptotic 
effects (Lei et al., 2003).  
 Concurrently, there is CHOP induction by PERK through ATF4 (Szegezdi E. 
et al., 2006). Expression of the anti-apoptotic BCL2 protein is directly suppressed by 
CHOP (McCullough et al., 2001). CHOP also enhances the induction of pro-apoptotic 
proteins such as GADD34 and ERO1 (Marciniak et al., 2004).  
 Additionally, UPR-induced apoptosis is also mediated through caspases. 
Procaspase 12 (pCP12) is activated when its association with TRAF2 is disrupted 
(Yoneda et al., 2001). During ER stress, conformational changes in Bax and Bak 
facilitate the entry of Ca2+ into cytosol, thereby activating m-Calpain, which 
subsequently cleaves and activates pCP12 (Nakagawa et al., 2000; Zong et al., 2003). 
Activated caspase-12 (CP12) then cleaves and activates procaspase-9, which in turn 
activates the downstream caspase cascade including caspase-3 (Morishima et al., 
2002; Tan, 2006). Further, the mitochondria can take up Ca2+ released from the ER 
and trigger release of cytochrome c into the cytoplasm (Crompton, 1999). This 





executioner caspase 3 (Rutkowski and Kaufman, 2004). Together, JNK, CHOP and 
caspases act synergistically to regulate the apoptotic effect during ER stress. 
 
 
Figure 1.3. ER stress pathways implicated in mediating cell apoptosis 
I: Activation of the PERK and ATF6 (not shown) pathways leads to the induction of 
CHOP, which downregulates the expression of the anti apoptotic protein Bcl2 and 
induces GADD34 and ERO1α. The latter promotes ER stress by increasing ER 
protein load (via translational recovery by eIF2α dephosphorylation) and altering ER 
redox conditions. II: Activated IRE1 binds JIK and recruits TRAF2, which leads to 
the activation of ASK1 and JNK. JNK phosphorylates Bcl2 and BH3 only protein 
(Bim), initiating mitochondria mediated apoptosis (not shown). III: Recruitment of 
TRAF2 to IRE1 also permits TRAF2 to dissociate from procaspase 12 (pCP12) 
residing on the cytoplasmic side of ER membrane, allowing pCP12 activation. During 
ER stress, Bax and Bak in the ER membrane oligomerize and allow the release of 
Ca2+ from the ER to the cytosol, which activates m Calpain, which subsequently 
cleaves and activates pCP12. Active caspase 12 (CP12) cleaves and activated 
procaspase 9, which in turn activates downstream caspases, including caspase 3. In 
addition, Ca2+ released from the ER is taken up by the mitochondria, causing 
mitochondrial inner membrane depolarization and cytochrome c release into the 
cytoplasm. This allows the formation of the apoptosome (consisting of Apaf1, 
cytochrome c, ATP and procaspase 9), activation of procaspase 9 and subsequent 





1.5 Ubiquitin Proteasome Pathway (UPP) 
 The Ubiquitin Proteasome Pathway (UPP) consists of concerted actions of 
enzymes that attach multiple ubiquitin (Ub) molecules to the target protein to mark 
them for degradation (Glickman et al., 2002; Pickart, 2004). This tagging process 
leads to their recognition by the 26S proteasome, a very large multi-catalytic protease 
complex that degrades ubiquitinated proteins to small peptides (Baumeister et al., 
1998). Covalent conjugation of ubiquitin onto proteins that are destined for 
degradation proceeds via a three step mechanism. Initially, E1 (Ub-activating 
enzyme) modifies and activates ubiquitin so that the C-terminal glycine on Ub will 
react with the lysine side-chains on the substrate protein. Following activation, E2 
(Ub-conjugating enzyme) catalyzes the attachment of Ub to the substrate protein. 
Finally, E3 (Ub-protein ligase), also the key enzyme in this process, works in concert 
with E2 enzymes in attachment of Ub to the substrate.  
1.6 Autophagy 
 Autophagy is a self-catabolic process where bulk cytoplasmic components and 
intra-cellular organelles are sequestered in double membrane vesicles called 
autophagosomes. The mature autophagosome eventually fuses with the lysosome, 
forming an autolysosome, in which its contents are degraded by lysosomal enzymes. 
In general, autophagy is seen to play a housekeeping role in removing misfolded or 
aggregated proteins, clearing damaged organelles, such as mitochondria, endoplasmic 
reticulum and peroxisomes, as well as eliminating intracellular pathogens. Currently, 
three types of autophagy have been identified: microautophagy, macroautophagy, and 





 In microautophagy, cytosolic components are directly taken up by the 
lysosome itself through invagination of the lysosomal membrane (Kunz et al., 2004). 
Nevertheless, this function in higher eukaryotes is unclear. Macroautophagy is the 
major regulated catabolic mechanism that eukaryotic cells use to degrade long-lived 
proteins and organelles and will be further discussed in the following section. 
1.6.1 Macroautophagy 
 This form of autophagy begins with an isolation membrane or phagophore, 
which expands to engulf the cytoplasmic material to be degraded, and sequesters the 
cargo in a double membrane autophagosome. The loaded autophagosome then fuses 
with lysosomes, forming autolysosomes. This allows the lysosomal enzymes to 
degrade the autophagosomal contents. Lysosomal permeases and transporters then 
export amino acids and other by-products of degradation back out to the cytoplasm, 
where they can be re-used for building macromolecules and for metabolism 
(Mizushima, 2007). Thus, this catabolic activity is often thought of as a cellular 
“recycling  factory”  that  enables  cells  to  restore  sufficient  energy  levels  in  the  absence  
of nutrients and consequently promotes viability (Huang et al., 2002). 
 This process is also orchestrated at the molecular level. The class III 
phosphatidyl inositol 3-kinase (PI3KC3), an ortholog of vesicular protein sorting 34 
(Vps34) mediates the initial formation of autophagic vacuoles (Kihara et al., 2001). 
Together with Beclin1 and other Autophagy-related genes (Atg) proteins, this 
complex controls the formation and elongation of phagophores (Suzuki et al., 2007; 
Obara et al., 2008). Conversely, the class I PI3K complex activates the AKT1 
pathway thereby activating the mammalian target of rapamycin (mTOR) and shuts off 





and decreases its affinity for Atg1, a serine/threonine kinase. In yeast, under 
conditions of nutrient deprivation, TOR is found to be deactivated and 
dephosphorylated by Atg13 which then binds Atg1 to activate autophagy (Kamada et 
al., 2000). However, the exact mechanism by which mTOR inhibits autophagy in 
mammalian cells remains unclear. Another negative regulator of autophagy is Bcl-2. 
Under normal conditions, Beclin 1 binds to the groove of Bcl-2 and Bcl-XL at the 
BH3 domain (Maiuri et al., 2007). Hence under stressful conditions, the dissociation 
of Beclin1 from Bcl-2/Bcl-XL allows Beclin1 to bind to Vps34 and induces autophagy 
(Pattingre et al., 2005).  
 Elongation of the autophagic vacuole membrane is mediated by the Atg5–
Atg12 conjugation step and the LC3 processing step (Kirkin et al., 2009). The Atg12–
Atg5 dimer is recruited to the outer autophagosomal membrane, presumably via 
interaction with Atg16. Atg 4, 7 and 3 cleave LC3 into LC3-II in a sequential manner 
whereby phosphatidylethanolamine is conjugated to. Finally, the Atg5–Atg12–Atg16 
complex induces hemi-fusion of membranes through a symmetric recruitment of 
processed LC3-II. The synthesis and processing of LC3 into LC3-II is increased 
during autophagy, making it a key readout of levels of autophagy in cells (Barth et al., 
2010). Autophagy is also identified by a punctuated immunofluorescence staining 
pattern. 
 Recently, autophagy has been shown to be a backup degradation system 
induced by ER stress and UPR. It is widely believed to be a compensatory protective 
mechanism to remove and recycle misfolded proteins and provide nutrients for the 
cell (Kawakami et al., 2009; Yorimitsu et al., 2006). On the other hand, during 





Klionsky, 2007). Till now, it remains controversial as to how ER stress activates 
autophagy. Nevertheless, strong evidence has shown to suggest that PERK which is 
activated by ER stress and is part of the UPR might be essential for ER stressed-
induced   autophagy   through   phosphorylation   of   eIF2α   and   activation   of   Atg12   in  
mouse embryonic fibroblast (MEF) and differentiated  p19 embryonal carcinoma 
C2C5 cells (Kouroku et al., 2007). Overall, more research is still required to define 
the molecular mechanisms underlying ER stress-induced autophagy. 
1.6.2 Chaperone-mediated autophagy (CMA) 
 Unlike microautophagy and macroautophagy, vesicular traffic is not involved 
in chaperone-mediated autophagy (CMA) (Cuervo et al., 1998; Dice, 2000; Franch et 
al., 2001). Substrate proteins with an exposed pentapeptide sequence related to 
KFERQ are preferentially recognised by a molecular chaperone complex consisting of 
the constitutive form of the heat shock 70 kDa protein (hsc70), the heat shock protein 
of 40 kDa (hsp40), the heat shock protein of 90 kDa (hsp90), the hsc70-interacting 
protein (hip), the hsc70-hsp90 organizing protein (hop), and the Bcl2-associated 
athanogene 1 protein (bag-1) (Agarraberes and Dice, 2001). The chaperone/proteins 
complex then interacts with the lysosomal membrane receptor lysosomal-associated 
membrane protein 2A (LAMP-2A) (Cuervo et al., 1996). Once bound to the 
lysosomal membrane, the substrate is unfolded (Salvador et al., 2000), presumably 
assisted by the molecular chaperone complex and with the help of lysosomal hsc70 
(ly-hsc70), the protein is pulled into the lysosomal lumen (Cuervo et al., 1997; 
Agarraberes et al., 1997). The ultimate fate of this protein is degradation by proteases 





1.7 Current perspective in APL and study hypothesis and objectives  
1.7.1 Current perspective in APL 
 It has previously been shown that misfolded conformation dependent loss 
(MCDL) of N-CoR played a role in the pathogenesis of APL. This loss of N-CoR is 
attributed to the expression of PML-RARα. Khan et al. have reported that PML-
RARα  could bind aberrantly to the N-CoR molecule. Such interaction could induce 
the N-CoR protein to adopt an abnormal conformation and subsequent degradation, 
thus disrupting its important role in the transcriptional control of several tumour 
suppressor proteins (Khan et al., 2001; 2004).  
 In addition to the loss of function effect due to misfolding, misfolded N-CoR 
could also contribute to APL pathogenesis through an aberrant gain of function 
properties. In an earlier study, a glycoprotease selectively expressed in APL cells has 
been shown to regulate the response of APL cells to UPR induced apoptosis through 
the processing of misfolded N-CoR protein (Ng et al., 2006). Ng et al. found that N-
CoR cleavage in APL cells by O-Sialoglycoprotein endopeptidase (OSGEP) protease 
reduced the ER stress to a level that was below the threshold needed to evoke the 
stress mediated apoptosis pathway thus allowing the cells to escape cell death. This 
unique cellular defense mechanism was termed   as   ‘late’   cytoprotective UPR which 
was activated when the early cytoprotective UPR failed to protect the cells from the 
harmful effect of misfolded proteins. The net outcome was resistance to UPR-induced 
apoptosis and uncontrolled proliferation of promyelocytic cells.  
 Further, there is preliminary evidence in our laboratory that indicated 
processing of misfolded N-CoR through a cytoprotective autophagic response not 





uncontrolled growth and proliferation of APL cells. It has been hypothesized that 
energy derived from the degradation of misfolded N-CoR protein through autophagy 
could sustain the growth of APL cells. A schematic representation of the regulation of 
UPR in APL cells is shown in Figure 1.4.  
 Apart from the elucidation of underlying molecular mechanism in APL 
pathogenesis, therapeutic modulation was also investigated. Ng et al. previously 
reported that PML-RARα mediated misfolding of N-CoR protein could be inhibited 
by genistein, a potent modifier of N-CoR protein conformation. The mode of action 
exerted by genistein was thought to be through the inhibition of selective 
phosphorylation-dependent binding of N-CoR to PML-RARα. This could have 
resulted in the dissociation of PML-RARα from N-CoR and restored N-CoR’s  growth  
suppressive function (Ng et al., 2007). More recently, Ng and colleagues 
demonstrated that curcumin promoted net accumulation of aberrantly phosphorylated 
misfolded N-CoR protein by blocking its ERAD and protease-mediated degradation. 
This resulted in the activation of UPR-induced apoptosis in APL cells (Ng et al., 
2011). 
 
1.7.2 Study hypotheses and objectives 
 The role of N-CoR in the cancer pathogenesis has been mostly studied in APL 
however its role in the pathogenesis in other solid tumours has yet to be established. 
Currently, there is limited information on the role of N-CoR in the pathogenesis of 
HCC. 
 HBX is known to be required to play multifunctional roles such as 
transcription modulation, protein degradation, cellular signalling pathways, cell cycle 





integrity of PML oncogenic domains (POD), of which N-CoR is an important 
component, was altered in several cases of viral infections (Day et al., 2004).   The 
findings provided clues that HBX, similar to PML-RARα might function as a 
transforming protein which may interfere with N-CoR protein. Further, the role of 
UPR in hepatocarcinogenesis has been demonstrated by Mashiro and colleagues 
where they found that UPR caused the activation of ATF6, XBP1 and GRP78 genes 
in human HCC (Masahiro et al., 2003).  
 
Figure 1.4. Kinetics of N-CoR misfolding in APL 
ER accumulated misfolded N-CoR cooperates with PML-RARα to trigger cell death 
initially, whereas this toxic effect is neutralised due to structural and functional 








 Given the apparent similarities and correlations between APL and HCC, we 
plan to investigate the role of N-CoR in HCC. The objectives of this study are as 
follows: 
1. to investigate if viral proteins can promote misfolding/loss of N-CoR; 
2.  to elucidate the molecular mechanisms underlying HCC   cells’   resistance   to  
 UPR induced apoptosis; 
3.  to investigate the molecular mechanism underlying the induction of autophagy 
 and their effects on growth of HCC cells and; 
4.  to evaluate the feasibility of therapeutic targeting of ER stress, UPR and 
 autophagy in HCC cells. 
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Chapter2. Materials and Methods 
2.1  Materials 
2.1.1  General Reagents 
 
Table 2.1. List of Chemicals, Reagents and Kits 
 
Chemicals/Reagents/Kits Company Country 
2-Mercaptoethanol Bio-Rad CA, USA 
4,6-diamidino-2 phenylindole (DAPI) Sigma Aldrich MO, USA 
1 kb DNA ladder Promega WI, USA 
30% Acrylamide-Bis Solution Bio-Rad CA, USA 
Agarose Bio-Rad CA, USA 
Ammonium Persulfate Bio-Rad CA, USA 
Bovine Serum Albumin (BSA) Sigma Aldrich MO, USA 
Diethylpyrocarbonate (DEPC) Sigma Aldrich MO, USA 
Dimethyl sulfoxide (DMSO) Sigma Aldrich MO, USA 
Dulbucco’s  Modified  Eagle’s  Medium  (DMEM) Sigma Aldrich MO, USA 
Ethanol Merck Darmstadt 
Fetal Bovine Serum (FBS) Hyclone Lab Logan, UT 
Fugene 6 Roche Germany 
Glacial Acetic Acid Merck Darmstadt 
Glycine Bio-Rad CA, USA 
Isopropanol Merck Darmstadt 
Lipofectamine 2000 Invitrogen CA, USA 
Luciferase Assay System (Dual) Promega WI, USA 
Methanol Sigma Aldrich MO, USA 
Murine Reverse Transcriptase (MMLV) Promega WI, USA 
Normal Goat IgG Santa Cruz CA, USA 
Normal Mouse IgG Santa Cruz CA, USA 
Normal Rabbit IgG Santa Cruz CA, USA 
Paraformaldehyde Sigma Aldrich MO, USA 
Phosphatase Inhibitor Cocktails 1 and 2 Sigma Aldrich MO, USA 
Precision Dual Colour Standard Protein Marker Bio-Rad CA, USA 
Prolong Gold Antifade Reagent Invitrogen CA, USA 
Protein G Sepharose Beads Roche Germany 
PVDF Membrane Bio-Rad CA, USA 
Qiagen plasmid DNA purification Kit   
(maxi and miniprep kit) 
Qiagen GmBH Hilden 
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Chemicals/Reagents/Kits Company Country 
Qiagen RNasey RNA extraction Kit  Qiagen GmBH Hilden 
Skim Milk powder Sigma Aldrich MO, USA 
Sodium Dodecyl Sulfate (SDS) Bio-Rad CA, USA 
Sodium Fluoride Sigma Aldrich MO, USA 
Tetramethylethylenediamine (TEMED) Bio-Rad CA, USA 
Tris-Base Bio-Rad CA, USA 
Trizol Sigma Aldrich CA, USA 
Tween 20 Sigma Aldrich MO, USA 
 
2.1.2  Antisera 
2.1.2.1 Western Blotting 
Table 2.2. List of Primary Antibodies 
 
Antibodies Description Ratio Source 
β-actin Mouse Monoclonal 1:10 000 Sigma Aldrich 
ATF6α Rabbit Polyclonal 1:5000 AbCam 
eIF2α Rabbit Polyclonal 1:1000 Cell Signalling 
FLAG Mouse Monoclonal 1:20 000 Sigma Aldrich 
HA Rabbit Polyclonal 1:1000 Santa Cruz 
GRP78 Goat Polyclonal 1:2000 Santa Cruz 
LC3 Rabbit Polyclonal 1:5000 Novus Biologicals 
Myc Rabbit Polyclonal 1:4000 Santa Cruz 
N-CoR Goat Polyclonal 1:500 Santa Cruz 
PDI Rabbit Polyclonal 1:2000 Santa Cruz 




Table 2.3. List of Secondary Antibodies 
 
Description Ratio Source 
HRP-Goat anti-Rabbit 1:10 000 Zymed Laboratories 
HRP-Goat anti-Mouse 1:10 000 Zymed Laboratories 







2.1.2.2 Immunofluorescence Staining 
Table 2.4. List of Primary Antibodies 
 
Antibodies Description Ratio Source 
FLAG Mouse Monoclonal 1:1000 Sigma Aldrich 
HA Rabbit Polyclonal 1:1000 Santa Cruz 
HBX Mouse Monoclonal 1:100 Santa Cruz 
LC3 Rabbit Polyclonal 1:300 Novus Biologicals 
N-CoR Goat Polyclonal 1:100 Santa Cruz 
PDI Rabbit Polyclonal 1:100 Santa Cruz 
 
Table 2.5. List of Secondary Antibodies 
 
Description Ratio Source 
Alexa Flour Chicken Anti-Goat 488 1:200 Invitrogen 
Alexa Flour Chicken Anti-Goat 594 1:200 Invitrogen 
Alexa Flour Chicken Anti-Mouse 488 1:200 Invitrogen 
Alexa Flour Chicken Anti-Mouse 594 1:200 Invitrogen 
Alexa Flour Chicken Anti-Rabbit 488 1:200 Invitrogen 
Alexa Flour Chicken Anti-Rabbit 594 1:200 Invitrogen 
 
 
2.1.3  Primer Sequences 
 
2.1.3.1 Semi-Quantitative RT-PCR primers 
 
Table 2.6. List of semi-quantitative RT-PCR primers 
 
Gene Sequence Annealing 
Temperature (oC) 
Cycles 
B2M F:  5’-ATCCAGCGTACTCCAAAGAT-3’ 
    R:  5’-TTACATGTCTCGATCCCACT-3’ 
58 30 
HBX F:  5’-GTACTGCCAACTGGATCCTTC-3’ 
 R:  5’-CCTCCCAGTCCTTAAACACAC-3’ 
56 38 
N-CoR   F:  5’-TACCGCAGGAGCCATACAAGA-3’ 
 R:  5’-GCTCAGTTGTGCTTTGGGAGC-3’ 
60 30 
Haptoglobin F:  5’-GCCTGGGCAACAGGAGTGAAA-3’ 
R:  5’-CTTGGTTGGTCTTGCCTCTGG-3’ 
60 35 
PAA-1  F:  5’-ACACATGCCTCAGCAAGTCC-3’ 
R:  5’-TCTTCTTGACAGCGCTCTTG-3’ 
60 35 



















Slug F:  5’-TGTGTCCAGTTCGCT-3’ 
R:  5’-ATGCCGCGCTCCTTCCT-3’ 
60 35 
Vimentin F:  5’-GAGAACTTTGCCGTTGAAGC-3’ 
R:  5’-TCCAGCAGCTTCCTGTAGGT-3’ 
60 35 




2.1.3.2 siRNA sequences 
Table 2.7. List of siRNA sequences used in siRNA mediated gene knockdown 
 
Target Sequence  
N-CoR 5’-AATGCTACTTCTCGAGGAAACA-3’  
Luciferase 5’-CGTACGCGGAATACTTCGA-3’  
 
2.1.4  Drugs and Inhibitors 
All drugs and inhibitors used were prepared as stock solutions and stored as aliquots at -20°C. 
 
Table 2.8. List of drugs and inhibitors 
 
Drugs/Inhibitors Stock Conc./ Solvent 
Preparation 
Source 
Bafilomycin (BA-1) 10µM with DMSO Sigma Aldrich 
DTT 1 M with deionised water Sigma Aldrich 
Genistein 20mM with DMSO Sigma Aldrich 








2.1.5  Hepatocellular Carcinoma Tissues 
2.1.5.1 Human Samples 
 Human liver tissues used in this study were obtained from 10 patients 
diagnosed with either moderately differentiated HCC or poorly differentiated HCC. 
All patients suffered from cirrhosis with chronic HBV infection. Tissues were 
collected from the tissue repository of National University Hospital (Singapore) and 
the use of these samples has been approved by NUS Institutional Review Board 
(IRB). Basic clinical data of the patients are presented in Table 2.9. Paired tissues 
were obtained from each patient, one from the tumour region of the resected liver and 
the other matching control from adjacent non-tumour (normal) region.  
 









cells in sample 
NT00/0036 73 MALE CHINESE 90%                     
MOD DIFF 
 





63 MALE CHINESE 100%                
POORLY DIFF 
 















46 MALE CHINESE 70%                    
MOD DIFF 
 





55 MALE CHINESE 80%                    
MOD DIFF 
 




2.1.5.2 Tissue Microarray 
 
 The custom tissue microarray from US Biomax was selected for our 
immunohistochemistry (IHC) studies. This tissue array includes the hepatic carcinoma 
as well as the normal tissues, containing 15 cases in early stage, 55 cases in advanced 
stage and 10 normal tissues.  
2.1.6  Cell lines 
 
2.1.6.1 Liver cancer cell lines 
 
 All HCC cell-lines: HepG2, SK Hep1, Huh7, PLC/Prf/5, Snu449, Snu387, 
Snu398, Snu423 and Snu475 were purchased from the American Type Culture 
Collection (Rockville, MD). For short-term storage, cells are suspended in freezing 
media [90% filtered FBS, 10% DMSO] and kept at -80°C. For long-term storage, 
cells were suspended in the same storage media and maintained in liquid nitrogen.  
 
2.1.6.2 HEK 293T and HeLa cell lines 
 
 Both 293T and HeLa cells were obtained from the American Type Culture 
Collection (Rockville, MD). Maintenance and storage of these cells were similar to 
liver cancer cells.  
 
2.1.7  Plasmids 
 
2.1.7.1  pACT vector 
  
 The pACT vector (Promega, USA) is a non-viral mammalian expression 
vector containing CMV promoter and carries the ampicillin bacterial resistance gene. 
pACT-NCoR-FLAG consists of 2 tandem repeats of Flag sequence, linked in frame to 




2.2  Methods 
 
2.2.1    Cell Culture Treatment 
 
2.2.1.1 Cell culture 
 
 All cells were cultured in Dulbecco’s  modified  eagle  medium  (Sigma Aldrich, 
USA) supplemented with 10% fetal bovine serum (FBS) (HyClone, Waltham, USA), 
at 37°C in a 5% CO2 humidified atmosphere. Media was changed every 3-4 days and 
cells were passaged by trypsinization with 0.5% (w/v) trypsin and 0.2% (w/v) 
ethylenediaminetetraacetic acid (EDTA) disodium salt when they reached 80-90% 
confluency. 
 
2.2.1.2 Treatment with drugs and inhibitors 
 
 Cells were seeded according to their treatment and doubling time. At the 
appropriate incubation or treatment time-point and confluence, cells were then 




2.2.1.3.1 DNA transfection of 293T cells and HeLa cells 
 293T or HeLa cells were seeded at 200X104 per 10-cm plate or 80X104 cells 
per 6-cm plate or 20X104 cells per well of a 6-well plate one day prior to transfection. 
Approximately 18-22 hours after seeding, transfection was carried out. Briefly, 
Fugene 6 (Roche, Germany) was first diluted in serum free medium for 5 mins at 
room temperature and indicated plasmids were then added to diluted Fugene (DNA: 
Fugene = 1 μg:3   μl). The mixture was incubated for further 15 mins at room 
temperature. The final DNA-Fugene 6-serum free medium mixture was then added 
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slowly in a drop wise manner to the cells. Cells were then incubated for at least 48 
hours before harvesting.  
2.2.1.3.2 N-CoR siRNA knockdown in HCC cells 
 The N-CoR siRNA was used to specifically knockdown the N-CoR gene in 
HCC cells. A mock siRNA targeting the luciferase sequence which could not be 
found in the mammalian genome was used as non-targeting siRNA control. Cells 
were seeded in a similar way as mentioned earlier. Roughly 18-22 hours after seeding, 
cells reaching about 60% confluency were transfected with either non-targeting 
control siRNA or N-CoR siRNA. The transfection mixture was prepared by first 
mixing DMEM containing the appropriate concentration of siRNA with DMEM 
containing LipofectAMINETM 2000 (Invitrogen, CA, USA). This mixture was then 
incubated at room temperature for 20 mins before adding to the respective seeding 
media. The transfected cells were subsequently returned to the CO2 incubator and 
incubated for 24-72 hours at 37°C. The effect of gene silencing was analysed by 
reverse transcription-polymerase chain reaction (RT-PCR).  
 
2.2.2  Protein extraction 
 
2.2.2.1 Mammalian cells 
 
 Cells were collected after trypsinization and pelleted by centrifuging at 200g 
for 5 mins at 4°C. The resulting pellet was rinsed twice with ice-cold 1X PBS (pH 
7.4) before centrifugation and the supernatant was then removed. Four pellet volume 
of 2X SDS sample buffer [250mM Tris-HCl (pH6.8), 40% glycerol, 9.2% SDS, 
0.01% bromophenol blue, 20% β-mercaptoethanol] was used to re-suspend cell pellet. 
Cells were then sonicated twice or thrice, 10 secs each, on ice using the Branson 
Sonifier 150 with an output power of 5W. The protein samples were then denatured 
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by heating at 50°C for 10 mins or 95°C for 5 mins. Protein samples were then loaded 
and resolved on SDS-PAGE. Protein quantification was determined after staining the 
gel with Coomassie Blue staining solution [0.25% Coomassie Blue, 10% (v/v) acetic 
acid, 50% (v/v) methanol] and Coomassie destaining solution [10% (v/v) acetic acid, 
50% (v/v) methanol]. Crude lysates were stored at -80°C. 
2.2.3  Immunoblotting/Western Blotting 
 Protein samples were resolved on SDS-PAGE using the Bio-Rad Mini-Protean 
II system. Electrophoresis was carried out at constant current of 10mA using cold 1X 
Laemli running buffer [25mM Tris, 192mM glycine, 0.1% (w/v) SDS] at 4°C. The 
proteins were then transferred onto Hybond-P Polyvinylidene Fluoride (PVDF) 
membrane (GE Healthcare, Uppsala, Sweden) using a wet transelectroblotting system 
(Bio-Rad Inc., England). The polyacrylamide gel was run at a constant current of 
60mA for 150 mins at 4°C in 1X transfer buffer [48mM Tris, 39mM glycine, 0.037% 
(w/v) SDS and 10% (w/v) methanol (added just prior to use)]. After transfer, 
membranes were blocked in PBS-T (1X PBS containing 0.1% Tween 20) containing 
5% milk [5% non-fat milk powder (Merck) in 1X PBS-T] for 1 hour at room 
temperature or overnight at 4ºC. After incubation in the appropriate primary antibody 
overnight at 4°C in the respective blocking buffers, the membrane was rinsed thrice 
with PBS-T for 10 mins each to remove any unbound antibodies. HRP-conjugated 
secondary antibodies with the blocking buffer were then applied for 1h at room 
temperature. The unbound secondary antibodies were removed by washing the 
membrane 5 times for 10 mins each with PBS-T before the detection of 
immunoreactive bands by Western Lightning Chemiluminescence Reagent Plus 
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(Perkin Elmer, CA, USA). The X-ray film was finally developed using a Konica 
Minolta SRX-101A film processor.  
 After immunodetection, the bound primary and secondary antibodies were 
removed from the membrane, which then can be re-probed with a different antibody. 
The developed membrane was briefly washed with PBS-T to remove residual 
chemiluminescence reagent and immersed in stripping buffer [glycine-HCl (pH2), 1% 
(w/v) SDS] for 30 mins with agitation. The membrane was rinsed with large volumes 
of PBS-T thrice for 10 mins each at room temperature and subsequently blocked with 
respective blocking buffers. The membrane was then re-probed by a different 
antibody using the same protocol described above. 
2.2.4  Immunohistochemistry 
 The paraffin-embedded human liver cancer tissue array was baked at 60°C to 
melt the wax and improve adhesion before staining. Immunohistochemical staining of 
tissue microarray was done using the goat ImmunoCruzTM Staining System (Santa 
Cruz Biotechnology, CA, USA). Briefly, sections were deparaffinised with histoclear, 
rehydrated in decreasing ethanol concentrations, and the antigens unmasked using 
1mM EDTA (pH8) at 95°C for 10 mins. Endogenous peroxidise activity was 
quenched using hydrogen peroxide, followed by incubating with 5µg goat anti-N-CoR 
(1:40) antibody for 2 hours at room temperature. The sections were then treated with 
labelled dextran polymer conjugated with HRP for 30 mins and further incubated with 
DAB+substrate chromogen solution for 5-10 mins. Sections were counterstained with 






2.2.5  Immunofluorescence and confocal microscopy 
 Cells were grown on coverslips in culture medium till 50-60% confluency 
before transfection or when 80-90% confluency reached for non treated cells. They 
were then fixed with 4% paraformaldehyde in PBS (freshly prepared and pre-warmed 
to 37°C) for 30mins at 37°C, washed thrice with 1XPBS before permeabilising with 
0.2% Triton X-100 in PBS on ice for 5 mins. Alternatively, cells were fixed and 
permeabilised with methanol at -20°C for 7 mins. After permeabilisation, cells were 
washed thrice with 1XPBS and blocked with 5% bovine serum albumin (BSA) in 
PBS for 30 mins. Cells were then incubated in primary antibodies at their appropriate 
dilutions for 2 hours at room temperature and subsequently washed with PBS thrice, 5 
mins each followed by incubation with the appropriate Alexa Fluor secondary 
antibodies (Invitrogen, Carlsbad, CA, USA) with 1:200 dilution, for 1 hour at room 
temperature in the dark. The cells were washed 3 times, 5 mins each after the 
incubation. The nuclei of the cells were counterstained with 150nM of 4,6-diamidino-
2-phenylindole (DAPI) for 5 mins. After washing the cells thrice with PBS, the 
coverslips with cells were mounted with SlowFade® Gold antifade reagent 
(Molecular Probes, CA, USA) before sealing with transparent nail polish. Images 
were subsequently visualized and captured using Axioplan 2 imaging fluorescence 
microscope (Carl Zeiss).  
2.2.6 RNA extraction 
 
2.2.6.1 Mammalian cells 
 
 Cells were collected after trypsinization and pelleted by centrifuging at 200g 
for 5 mins at 4°C. The resulting pellet was then washed twice with ice-cold 1X PBS 
(pH 7.4) and the supernatant aspirated completely after another round of 
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centrifugation. Purification of total RNA was then carried out using RNeasy Mini kit 
(Qiagen, Hilden, Germany)  according   to   the  manufacturer’s  protocol.  Up to 1 x 107 
cells, depending on the cell line, were disrupted in Buffer RLT (10   µl   β-
mercaptoethanol per 1ml Buffer RLT was added before use) and homogenized using 
needle and syringe. 1 volume of 70% ethanol was added to the homogenized lysate, 
creating conditions that promote selective binding of RNA to the RNeasy membrane. 
The sample was then loaded to the RNeasy Mini spin column. Total RNA was bound 
to the membrane and contaminants were efficiently washed away with buffers RW1 
then RPE. Lastly, high-quality RNA was eluted in 30-50µl of RNase-free water. All 
binding, washing, and elution steps were performed by centrifugation in a 
microcentrifuge. Purified RNA was eluted and its concentration was determined using 
Nanodrop Spectrophotometer ND-1000 (Thermo Fisher Scientific, Lafayette, CO, 
USA).  
 
2.2.7  Reverse transcription polymerase chain reaction (RT-PCR) amplification 
 
 Briefly, 3-5µg of purified RNA template was used for cDNA synthesis using 
RT-PCR System kit (Promega, WI, USA). Reverse transcription was performed at 
42°C for 1 hour, followed by 65°C for 15 min. cDNA synthesis was completed after 
inactivation of transcriptase by incubation at 95°C for 5 mins. cDNA was either 
stored at 4°C or on ice for immediate analysis or stored at –20°C until use. 
 PCR amplification was carried out as shown in Table 2.10 using Thermal 
Cycler GeneAmp®PCR System 9600 (Applied Biosystems, CA, USA). Depending 
on the different primers used, the annealing temperature and number of cycles were 





Table 2.10. PCR amplification steps. *30-35cycles (Steps2-4) 
 
Steps Temperature (°C) Time 
1. Initializing 94 5mins 
2. Denaturation 94* 30s 
3. Annealing 60* 30s 
4. Extension/Elongation 72* 30s 
5. Final Elongation 72 7mins 
6. Final Hold 4  
 
   
2.2.7.1 DNA agarose gel electrophoresis 
 Gene expression analysis was carried out by agarose gel electrophoresis where 
PCR products were resolved in 1% w/v agarose gel (1g of electrophoretic grade 
agarose powder in 100ml 1XTAE buffer [40mM Tris-acetate (pH7.8), 1mM EDTA] 
stained with Gel Red at a 1:10000 dilution and expression levels visualized using 
Trans UV on the Gel Doc System (Bio-Rad, CA, USA). 
 
2.2.8  Biological Assays 
 
2.2.8.1 Luciferase assay 
 
 The effect of N-CoR and viral proteins on promoter activity of ATF6-
luciferase activity was carried out using the Dual-Luciferase® Reporter (DLRTM) 
Assay System Kit (Promega, WI, USA) as described by the manufacturer. Hela cells 
were co-transfected with ATF6 reporter plasmid containing the firefly luciferase 
reporter gene under the control of the CMV promoter and tandem repeats of ATF6 
transcriptional response element, together with different combination of other 
plasmids. After transfection, cells were lysed in 1X Passive Lysis Buffer (PLB).  The 
firefly luciferase reporter was measured first by adding Luciferase Assay Reagent II 
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(LAR II) to generate a luminescent signal lasting for at least one minute. After 
quantifying the firefly luminescence, this reaction was quenched, and the Renilla 
luciferase reaction was initiated simultaneously by adding Stop & Glo® Reagent to 
the same sample. The apparent luminescence activity was measured using the Sirus 
Single Tube Luminometer (Berthold Detection System, Germany). The light signal 
was integrated for 10 secs after a delay of 1 sec. Each sample was assayed in 
triplicate.  
 
2.2.8.2 ATP assay 
 
 Measurement of internal ATP of the mammalian cells was performed using 
the ATP Bioluminescence Assay Kit HS II (Roche, Germany). After the knockdown, 
1 X 105 live cells were pelleted, washed with ice-cold 1XPBS and re-suspended in 
dilution buffer to a cell concentration of 1X105 cells/ml. Cell lysis buffer was then 
added and the mixture was incubated at room temperature for 5 mins. Finally, 
luciferase regent was added to the crude lysate and luminescence activity was 
measured using the Sirus Single Tube Luminometer (Berthold Detection System, 
Germany). The light signal was integrated for 10 secs after a delay of 1 sec. Each 
sample was assayed in triplicates.  
 
2.2.8.3 Ubiquitination assay/ Immunoprecipitation 
 
 Cell were harvested in 4X pellet volume of lysis buffer [10mM Tris-HCl 
(pH8), 500mM NaCl, 2% SDS], heated at 95°C for 10mins and diluted with dilution 
buffer (lysis buffer:dilution buffer = 1:9) [10mM Tris-HCl (pH8), 500mM NaCl, 1% 
Triton-X-100), sonicated mildly twice for 10s on ice. The cell lysate was then 
incubated for 2.5 hours at 4°C with rotation with 5µg of either anti-Flag or anti-N-
CoR antibodies (Santa Cruz Biotechnology, CA, USA) and anti-mouse or anti-goat 
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IgG antibodies (Santa Cruz Biotechnology, CA, USA) were used as controls. After 
pre-adsorption with protein G- Sepharose beads (GE Healthcare Bio-Sciences AB, 
Sweden) for 2 hours at 4°C with rotation, the immunocomplexes were pulled down, 
added   to   2X   SDS   sample   buffer   containing   20%   β-mercaptoethanol and heated at 
50°C for 10 mins. The eluted proteins were then subjected to SDS-PAGE. 
  
2.2.8.4 Solubility assay 
 
 Cells were harvested in cell lysis buffer [50mM Tris-HCl (pH8.8), 100mM 
NaCl, 5mM MgCl2, 0.5% NP-40, 5mM PMSF, 1µg/ml leupeptin, 1µg/ml pepstatin, 
1µg/ml aprotinin] and lysed at 4°C with rotation for 30mins. The lysates were then 
centrifuged at 15 000rpm at 4°C for 10mins. The supernatant was aspirated as soluble 
fraction while the pellet was collected as insoluble fraction. The pellet was rinsed 
again with lysis buffer and supernatant was completely aspirated to avoid cross 
contamination. Pellet was then redissolved in pellet buffer [20mm Tris-HCl (pH8), 
15mM MgCl2], treated with DNase I (5µl per 250µ of pellet buffer) for 30mins at 
37°C. Prior to running on SDS-PAGE, SDS sample buffer was added to both soluble 
and insoluble fractions separately and heat inactivated at 50°C for 10 mins.  
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 Chapter 3. Results 
3.1 Analysis of N-CoR status in human liver cancer cells and tumours 
3.1.1 Loss of N-CoR protein in multiple human liver cancer cell lines 
 The role of misfolded conformation dependent loss (MCDL) of N-CoR protein 
in the pathogenesis of APL has been previously reported (Khan et al., 2004; Ng et al., 
2006, 2007). However, loss of N-CoR by MCDL has not been explored in liver 
cancer (HCC). In this study, a small scale screening of multiple liver cancer cell lines 
was performed to examine the expression of N-CoR at the protein and transcript level 
through western blotting assay and semi-quantitative PCR respectively. As shown in 
Figure 3.1 A-B, majority of liver cancer cells displayed N-CoR loss at protein but not 
mRNA level, which suggested that N-CoR loss occurred at post transcriptional level.  
3.1.2 Loss of N-CoR protein in human liver cancers 
 To examine how this loss of N-CoR protein was associated with the malignant 
phenotype of liver cancer cells, we performed a comprehensive analysis of N-CoR 
expression status in human primary cancer cells using western blotting assay. A 
comparative analysis of endogenous N-CoR protein level in 10 primary liver cancer 
patient samples with a history of HBX infection was performed. Matching non-
malignant tissues were used as controls. As expected, we observed a significant level 
of N-CoR loss in liver tumour specimens (Figure 3.2). However, a surprising 
observation was that there was a complete loss of N-CoR protein in non-tumour tissue 
surrounding the tumor. As the normal tissue was a matching control from the same 
patient, it was thought that these tissues may have acquired early malignant changes 
and N-CoR loss could be an early oncogenic event. 









Figure 3.1. Selective loss of N-CoR protein in HCC cells  
N-CoR expression at protein (A) and transcript (B) level in various liver cancer cells 
was determined through western blotting assay and RT-PCR analysis respectively. 
(A) Whole cell extracts of the various cell lines was resolved in SDS-PAGE and 
stained with N-CoR antibody in western blotting assay. Coomassie Blue staining and 
β2M  were  used  as  loading  controls.  Majority of HCC cells displayed loss of N-CoR at 







Figure 3.2. Evidence of N-CoR loss in primary human liver cancer samples 
Frozen pellets of patient samples were lysed using SDS lysis buffer. SDS-PAGE was 
used to resolve the whole cell lysates and N-CoR protein was visualized via western 
blotting with N-CoR antibody. HepG2 was included as a positive control. N denotes 
normal (adjacent non-tumour) while T denotes tumour. Similar to the cell line system, 
full length N-CoR protein was not present in these patient samples.  
 
3.2  Elucidating the mechanism of N-CoR loss 
3.2.1 N-CoR loss in HCC cells is linked to misfolding 
 It has been previously reported in APL that genistein, a tyrosine kinase 
inhibitor, from soybean can effectively stabilize N-CoR protein by restoring its native 
conformation (Ng et al., 2007). Hence, to investigate if degradation of N-CoR protein 
in HCC cells was due to misfolding, the effect of genistein on N-CoR was evaluated 
in SK Hep1 which was selected as a representative N-CoR negative HCC cell line. 
Our western blot data revealed that genistein promoted stabilization of N-CoR at a 
concentration of 25µM (Figure 3.3) which suggested that loss of N-CoR could be due 
to its misfolded conformation.  
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Figure 3.3. Genistein promotes stabilization of N-CoR protein in SK Hep1 cells 
Cells were treated with 25µM of genistein for 72 hours and the level of full length N-
CoR protein was determined by western blotting assay. 
 
 
3.2.2 Inverse relationship between N-CoR and HBX expression levels 
 Khan et al. has previously reported that PML-RARα, the transforming protein 
in APL, could induce N-CoR misfolding and its subsequent loss in APL (Khan et al., 
2004). Based on that, we hypothesized that an oncogenic protein present in liver 
cancer cells could also contribute to the misfolding and eventual loss of N-CoR 
protein in HCC. HBX has been reported to be the most common oncogenic factor in 
hepatocarcinogenesis (David, 2006). Therefore, we analysed HBX transcript 
expression via semi-quantitative PCR analysis and found HBX transcripts to be 
inversely correlated with N-CoR protein level (Figure 3.4). The transcript level of 
HBX was significantly higher in cell lines that displayed loss of N-CoR protein. 






                 
Figure 3.4. N-CoR protein level in HCC cells is inversely related to HBX     
                   transcript level 
 
Semi-quantitative RT-PCR analysis of HBX gene in various HCC cell lines revealed 
an inverse relationship to N-CoR protein. High level of N-CoR protein and negligible 
level of HBX transcripts was found in HepG2 cells, whereas the HBX positive cells 
displayed low level of N-CoR protein but high level of HBX transcripts.  
 
 
3.2.3 Co-expression with HBX preferentially localizes N-CoR to the cytosol 
 
 The data presented so far suggested that level of N-CoR protein might be 
regulated by HBX. To further characterize the role of HBX in HCC, we assessed 
whether ectopic expression of HBX could induce N-CoR localization to the cytosol. 
In this study, HBX was co-transfected with green fluorescent protein (GFP)-tagged N-
CoR expression vector in 293T cells and N-CoR localization was determined by the 
detection of green fluorescence signals. Fluorescence microscopy analysis showed 
that N-CoR was preferentially localized to the cytosol in the presence of HBX while 
N-CoR was localized mainly in the nucleus when co-expressed with the empty vector 
(Figure 3.5). It has been previously reported that functional N-CoR protein was 
localized in the nucleus while misfolded N-CoR to be localized in the cytosol (Khan 
et al., 2004; Ng et al., 2006, 2007), suggesting that aberrant sub-cellular distribution 
is an important hallmark of misfolded N-CoR. Taken together, HBX was thought to 





Figure 3.5. HBX promotes cytosolic retention of N-CoR protein 
Sub-cellular distribution of N-CoR (Green Fluorescence) protein was determined by 
immunofluorescence staining. Preferential localization of N-CoR to the cytosol was 
observed after co-expression with HBX while N-CoR was localized mainly in the 





















3.2.4 N-CoR in HBX positive HCC cells is found to be co-localized with HBX in 
 the cytosol 
 
 To validate the finding observed in 293T cells, immunofluorescence (IF) 
analysis of the distribution of endogenous N-CoR and HBX was performed in HCC 
cells. Consistent with the observation in 293T cells, a majority of N-CoR protein was 
found to be localized in the cytosol of HBX positive HCC tumour cells while in HBX 
negative HepG2 cells, N-CoR displayed a predominantly nuclear localization (Figure 
3.6). It was also observed that N-CoR co-localized with HBX in the cytosol of HBX 
positive HCC cells as indicated by the yellow signals (Figure 3.6, overlay).  
 
3.2.5 N-CoR protein in liver tumour sections is also found to be localized in the 
 cytosol 
 
 To further determine if the misfolding of N-CoR might be prevalent in liver 
cancer tissue sections, sub-cellular distribution of N-CoR in human liver tissue 
sections (from tissue microarray) was determined by immunohistochemistry (IHC) 
assay with N-CoR antibody. Consistent with the findings in liver cancer cell lines, N-
CoR was observed to be predominantly distributed in the cytosol of liver cancer tissue 
sections. In contrast, N-CoR was found predominantly in the nucleus of normal liver 
tissue sections  (Figure 3.7).  
 However, it should be highlighted that there is discrepancy of N-CoR 
detection between Western Blotting and immuno-blotting studies in Figure 3.1A and 
Figure 3.6 as well as in Figure 3.2 and Figure 3.7. This can be accounted by the fact 
that since N-CoR is degraded, there is no full length protein; however, the whole 
protein does not disappear with the fragments still present. Thus, in Western blot, the 
full length N-CoR protein was not detected but in IF/IHC, N-CoR protein fragments 






   









       Figure 3.6. N-CoR of HBX positive HCC cells is found in the cytosol 
Sub-cellular distribution of endogenous N-CoR and HBX protein in HepG2 and HBX 
positive HCC cells was determined with N-CoR and HBX antibodies respectively, 
followed by fluorescence labelled secondary antibodies. Signals were acquired 
through fluorescence microscopy. Green signal represents N-CoR distribution while 
HBX is represented by the red signals. Nucleus is stained with DAPI and is 
represented by blue signals. In HepG2, majority of N-CoR signal was detected in the 
nucleus overlapping the DAPI signal. However, in HBX positive cells, a significant 
portion of N-CoR protein was found in the cytosol where it co-localized with HBX 





Figure 3.7. N-CoR protein is mainly localized in the cytosol in tumour sections 
Human liver cancer tissue sections were stained with N-CoR antibody. The brown 
stains mark the N-CoR protein while the blue stains indicate nuclear location. In 
tumour tissue sections, N-CoR was localized in the cytosol while in normal tissue 






3.2.6 HBX induces N-CoR insolubility 
  Apart from aberrant cytosolic localization, detergent insolubility is another 
hallmark of misfolded proteins. Ng et al. has previously reported that natively folded 
N-CoR protein was soluble in a buffer containing organic detergent NP-40 while 
misfolded protein was insoluble in the same buffer. Thus, based on this report, 
solubility assay was carried out to further validate the protein conformation defect 
observed earlier in IF and IHC. We co-transfected 293T cells with flag-tagged N-CoR 
and either HBX or empty vector and the solubility of ectopically expressed N-CoR 
protein was determined by immunoblotting of soluble and insoluble fractions with the 
Flag antibody. In contrast to the N-CoR expressed alone, a significant amount of N-
CoR protein co-expressed with HBX was found in the insoluble fraction (Figure 3.8). 
This result suggested that HBX could trigger N-CoR misfolding. As a control to 
determine cross contamination of the fractions, Coomassie Blue staining was done. 
Coomassie staining data showed that there was no cross contamination of the 
fractions which indicated that higher amount of insoluble fraction seen was not due to 
spill over from the soluble fraction.  
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Figure 3.8. HBX can induce N-CoR insolubility 
Relative solubility/insolubility of N-CoR protein in transfected 293T cells was 
determined by protein solubility assay. Soluble and insoluble fractions were separated 
by high speed centrifugation and N-CoR level in each fraction was determined by 
western blotting assay using Flag antibody. Actin was used as a loading control while 
Coomassie blue staining was used to determine the level of total protein. 
 
 
3.2.7 HBX promotes degradation of ectopic N-CoR in transfected 293T cells 
 The data obtained so far suggested that HBX could be directly linked to N-
CoR misfolding in HCC. Since misfolding causes protein instability leading to its 
degradation, we decided to investigate whether HBX-induced N-CoR misfolding 
could lead to degradation.  293T cells were transfected with flag-tagged N-CoR alone 
or with HBX and level of flag-tagged N-CoR protein was detected by western 
blotting. As shown in Figure 3.9, the level of ectopic flag-tagged N-CoR in 293T cells 
co-transfected with the HBX plasmid was significantly lower than that of cells 
transfected with N-CoR-flag plasmid alone. This data suggested that HBX could 





Figure 3.9. HBX promotes N-CoR degradation 
 
Western blot analysis of flag-tagged N-CoR expressed in 293T cells with or without 
HBX showed N-CoR degradation in the presence of HBX. 
 
3.2.8 HBX promotes ubiquitin-proteasome mediated degradation of N-CoR 
 Poorly assembled and misfolded secretory proteins are known to be 
ubiquitinated and degraded by the ERAD-mediated protein quality control mechanism 
(Wickner et al., 1999; Pickart, 2001). This raises the question of whether N-CoR loss 
in HCC is ERAD-mediated. To test this, effect of MG132 (proteasome inhibitor) on 
HBX-induced N-CoR degradation was determined. Significant level of N-CoR 
stabilization after MG132 treatment of 293T cells was observed (Figure 3.10A). This 
result suggested the involvement of proteasome in HBX mediated N-CoR loss. In 
addition, misfolded proteins which are degraded via the proteasome usually exhibit 
high levels of ubiquitination. Therefore to test whether HBX-induced N-CoR 
degradation is preceded by ubiquitination, ubiquitination assay was performed. 293T 
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cells were co-transfected with N-CoR flag and ubiquitin-myc plasmids in the presence 
or absence of HBX. These transfected cells were then treated with proteasome 
inhibitor MG132 to block proteasome-mediated degradation. The results showed that 
level of ubiquitinated N-CoR (Ub-N-CoR) in HBX co-transfected cells was 
significantly higher when compared to cells lacking HBX (Figure 3.10B, upper 
panel). Ubiquitinated N-CoR was not detected in cells transfected with only N-CoR 
Flag, which indicated low levels of background ubiquitination (Figure 3.10B, lane 1). 
In addition, the amount of immunoprecipitated (IP) N-CoR was found to be similar in 
all experimental setups (Figure 3.10B, lower panel) despite the significant differences 
observed in the level of ubiquitinated N-CoR. Hence, the significantly higher levels of 
ubiquitinated N-CoR observed could be attributed to the presence of HBX and not to 
an unequal amount of N-CoR pulled down from the cells. 
 
3.2.9 N-CoR loss in HBX positive HCC cells is mediated by the ubiquitin-
 proteasome pathway 
 
 To investigate if N-CoR is also ubiquitinated in liver cancer cell lines, SK 
Hep1 cells were treated with MG132 to determine the levels of ubiquitinated N-CoR. 
SK Hep1 cells were selected in this study as treatment of MG132 could restore the 
expression of N-CoR in these cells (Figure 3.11A). Extracts from MG132 treated 
tumour cells were prepared in ubiquitination buffer and the endogenous level of 
ubiquitinated N-CoR protein was detected after immunoprecipitation with N-CoR 
antibody. We observed that the level of ubiquitinated N-CoR was significantly higher 
in MG132 treated HBX positive SK Hep1 cells when compared to untreated cells 
(Figure 3.11B, upper panel). This finding suggested that similar to 293T cells 
transfected with HBX, N-CoR in the HBX positive SK Hep1 cells could have been 
degraded via the ubiquitin-proteasome mediated pathway.  
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 It should be noted that the detection of N-CoR in input but not in IP was due 
to the low IP efficiency (usually around 1%-5%). N-CoR protein was still detectable 
in direct Western Blot, even if its level was low; however, since the level of N-CoR 
protein was already low, the amount of immunoprecipitated N-CoR was probably so 
















Figure 3.10. HBX promotes ubiquitination of N-CoR protein 
 
(A) Treatment with 10µM MG132 for 12 hours stabilized N-CoR protein in HBX co-
transfected 293T cells. (B) In this ubiquitination assay, transfection with various 
combinations of plasmids as mentioned on top of each lane was first done, then N-
CoR-flag protein was immunoprecipitated, and the immunocomplexes were detected 
with Myc antibody.  A significant elevated level of ubiquitinated N-CoR in the HBX 
co-transfected 293T cells was observed (upper panel). The membrane was re-probed 
with Flag antibody to ensure that the immunoprecipitated (IP) protein was N-CoR in 












Figure 3.11. Ubiquitin-proteasome mediated degradation of N-CoR protein in 
            HBX positive HCC cells 
(A) SK Hep1, a HBX positive HCC cell, was treated with proteasome inhibitor 
MG132 at 10 µM for a duration of 12 hours and level of full length N-CoR protein 
was determined by western blotting assay. There was stabilization of endogenous N-
CoR protein by MG132. (B) Endogenous N-CoR protein in SK Hep1 cells treated 
with MG132 was immunoprecipitated with N-CoR antibody and level of 
ubiquitinated (Ub) N-CoR was determined by western blotting assay with Ub 
antibody (upper panel). The high level of Ub-N-CoR seen in MG132 treated cells 
indicated that N-CoR loss could be ubiquitin-proteasomal mediated. The membrane 
was then re-probed with N-CoR antibody to quantify the amount of 
immunoprecipitated (IP) N-CoR protein (middle panel). Level of N-CoR protein 
(input) in each starting sample was determined in western blotting assay with N-CoR 








3.3 The role of misfolded N-CoR in HBX-induced UPR 
3.3.1 HBX positive HCC cells exhibit amplification of ER stress 
 It was hypothesized that misfolded proteins can trigger ER stress and activate 
the UPR. Hence, to investigate the potential link between misfolded N-CoR protein 
and ER stress, levels of three ER stress markers in HCC cells were determined by 
western blotting assay. Amplification of ER stress is normally characterized by the 
presence of high molecular weight (HMW) PDI, GRP78 and phosphorylation of eIF-
2α (peIF-2α). As expected, the relative level of HMW PDI was higher in most HBX 
infected HCC cells when compared to HepG2 expressing native N-CoR (Figure 
3.12A). In parallel, Figure 3.12B displayed slightly diminished levels of peIF-2α in 
HepG2 when compared to other HBX positive cells. The equal levels of eIF-2α  
detected in all the cells proved that lower level of peIF-2α  observed  in  HepG2  could 
be attributed to lower ER stress. Additionally, there was a considerably high level of 
GRP78 in all HCC cell lines which implied the existence of high ER stress (Figure 
3.12C). There was no marked decrease in GRP78 level in HepG2 though. Overall, 
Figures 3.12A-C illustrated evidences of amplification of ER stress in HBX positive 
HCC cells exhibiting N-CoR loss. 
 Immunostaining of selected HBX positive HCC cells was performed to verify 
the western blot data. PDI displays cytosolic localization as it is an ER-resident 
protein. Sub-cellular distribution of N-CoR, together with PDI, was determined by co-
staining HCC cells with N-CoR and PDI antibodies. Figure 3.12D showed that N-
CoR and PDI signals were localized in the nucleus and cytosol respectively in HepG2 
cells. In contrast, there was a significant co-localization between N-CoR and PDI in 
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Figure 3.12. HBX positive cells exhibit high level of ER stress  
Level of ER stress in HepG2 and HBX positive HCC cells was determined by the 
levels of high molecular weight (HMW) PDI protein (A), phospho-eIF2α  (B)  as  well  
as GRP78 protein (C). Overall, most HBX positive cells exhibited high level of ER 
stress. (D) Sub-cellular localization of N-CoR and ER resident protein PDI in HCC 
cells was evaluated by fluorescence microscopy after co-staining the cells with N-
CoR antibody (green signal) and PDI antibody (red signal). DNA was stained with 
DAPI (blue signal). Significant co-localization (yellow signal) between N-CoR and 
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3.3.2 HBX promotes ATF6 activation  
 Published reports have shown that upon ER stress, unfolded protein response 
(UPR) can initiate proteolytic processing of ATF6, creating a cleaved N terminal 
fragment of 50 kDa which translocates to the nucleus and then activates the 
transcriptional activity of the genes encoding ER chaperones and pro-apoptotic 
machinery (Ma and Hendershot, 2004). In view of this information, we investigated 
the status of ATF6 activation in HCC cells by determining the level of cleaved 50 
kDa fragment of ATF6 (N) in western blotting with ATF6 antibody. A processed 
form of ATF6 (N) was detected in all HBX positive HCC cells which indicated that 
these cells were in a state of elevated ER stress and that UPR was activated (Figure 
3.13A).  
 Based on this observation, we hypothesized that UPR might be triggered by the 
accumulation of HBX-induced misfolded N-CoR protein. To test this hypothesis, 
HeLa cells were co-transfected with HA-tagged ATF6 (HA-ATF6), in which HA was 
tagged in frame to ATF6 sequence, with N-CoR or HBX plasmids. Since dithiothreitol 
(DTT) treatment has been reported to induce ATF6 activation, HeLa cells transfected 
with HA-ATF6 alone and treated with DTT was included as a control (Ng et al., 
2006). This experiment was performed in HeLa cells because these cells have been 
frequently used in studies of the ER stress-induced activation of ATF6. As expected, 
ATF6 processing was observed in HeLa cells co-transfected with N-CoR, HBX and 
HA-ATF6; in contrast no ATF6 processing was observed when ATF6 was expressed 
alone (Figure 3.13B).  
 Simultaneously, IF assay was carried out to further confirm that HBX-induced 
N-CoR misfolding triggers the UPR event. Transfection of HeLa cells was done in a 
similar way to the experiment mentioned above. Cells were then stained with HA 
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antibody for ATF6 detection and DAPI for nuclear staining. Intensity of ATF6 (red) 
signals in the nucleus of HeLa cells increased significantly when ATF6 was co-
transfected with N-CoR and HBX (Figure 3.13C). Conversely, intensity of ATF6 
signals appeared to be weaker in the other sets of transfected cells. The increased 
nuclear staining of ATF6 in N-CoR and HBX transfected cells could be due to the 
nuclear localization of cleaved 50 kDa HA tagged ATF6 fragment. This data 
corroborated with the findings of western blot analysis.  
  
3.3.3 HBX abrogates N-CoR mediated repression of the ATF6 promoter 
 To further investigate the regulation of UPR by HBX and N-CoR, we 
determined ATF6 activity by studying the relative induction of a reporter containing 
5XATF6 response element through luciferase assay in HeLa cells. As presented in 
Figure 3.14, dose dependent reduction in ATF6 luciferase activity was achieved when 
N-CoR was ectopically introduced in HeLa cells. This trend was reversed when HBX 
was ectopically introduced in a dose dependent manner. Consistent with N-CoR’s  role  
as a transcriptional repressor, our data suggested that N-CoR could block ATF6 
activation, leading to UPR inhibition. On the other hand, HBX abrogated the N-CoR 
mediated repression of ATF6 as ATF6 activity was restored to its original level in the 
presence of HBX. This finding further supports the role of HBX-induced misfolded 














Figure 3.13. Regulation of UPR by HBX and N-CoR  
(A) Whole cell lysates were used for western blotting with the ATF6 antibody. P and 
N indicated the position of precursor and nuclear (activated) forms of ATF6 protein. 
ATF6 precursor was cleaved in all the HCC cells. (B) Processing of ATF6 was 
determined in HeLa cells transfected with HA-ATF6 along with plasmids mentioned 
on top of each lane. In the first lane, extract of cells treated with DTT was used as 
positive control. Precursor and processed ATF6 proteins were detected with HA 
antibody. Proteolytic cleavage of ATF6 protein was seen in HeLa cells co-transfected 
with N-CoR and HBX. (C) HeLa cells were transfected with the HA-ATF6 plasmid, 
together with the various combinations of plasmids as shown on the left of each row. 
Sub-cellular localization as well as intensity of ATF6 (red) signal was determined 
using fluorescence microscopy. Strong intensity of red signals was detected in the 
presence of N-CoR and HBX, suggesting that HBX-induced misfolded N-CoR could 







Figure 3.14. Ectopic expression of HBX in HeLa cells repressed ATF6 promoter  
           activity 
Effect of ectopic N-CoR on the activity of ATF6 promoter in HeLa cells transfected 
with varying concentrations of N-CoR-flag plasmid was determined in standardized 
luciferase assay. The value presented in each bar represents the average of three 
independent experiments. HBX blocked the N-CoR-induced repression of ATF6 




3.4 Investigating the molecular mechanism underlying the misfolded N-CoR    
            induced transformation of HCC cells 
  
 Several mechanisms have been implicated in the pathogenesis of HCC. In 
particular, some pathways, for example chronic inflammation, EMT and autophagy 
are known to be regulated by normal N-CoR. Based on this; we tested which of these 
mechanisms would be activated due to N-CoR misfolding.  
A. N-CoR misfolding and Chronic inflammation 
3.4.1 Upregulation of APR gene transcript in HCC cells 
 In hepatic cells, N-CoR has recently been identified as a negative regulator of 
a set of pro-inflammatory genes known as acute phase response (APR) genes which 
include haptoglobin, Serum Amyloid   A   (SAA)   fibrinogen   β   and   PLAT (PAA-1) 
(Nicolas et al., 2010). Based on this report, we hypothesized that natively folded N-
CoR could play a role in the repression of APR genes in normal liver cells whereas 
HBX-induced misfolded N-CoR in HBX-positive HCC cells could have led to de-
repression of these genes. To test this hypothesis, we determined the level of 
transcript of these 3 APR genes in HCC cells through semi-quantitative RT-PCR. The 
result showed that expression levels of the 3 APR genes across all HBX-positive HCC 
cells was considerably high (Figure 3.15). This suggested that HBX-induced N-CoR 
misfolding and subsequent loss may have abrogated its transcriptional ability to 
repress the APR target genes.  
 
3.4.2 Pro-inflammatory cytokine abrogates N-CoR function 
 The inverse correlation between N-CoR and APR genes suggests that pro-
inflammatory oncogenic signal could drive liver transformation by overriding the N-
CoR mediated transcriptional control of pro-inflammatory APR genes. To verify this 
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hypothesis, the induction of degradation of N-CoR upon stimulation with an 
oncogenic pro-inflammatory signal was determined. Since IL-1β  has  been  reported to 
induce the dissociation of N-CoR or SMRT co-repressor complexes from APR 
promoters (Nicolas et al., 2010), we stimulated HepG2 cells (has intact N-CoR) with 
2.5nM and 5.0nM 1L-1β   for   4   hours   and   determined the status of N-CoR protein 
through western blot. Figure 3.16 showed that in comparison to the untreated cells, 
the level of N-CoR protein was greatly diminished upon induction with IL-1β.  Taken 
together, we thought that N-CoR loss could contribute to the transformation of HCC 
cells through a change of cellular response to inflammation.       
 
Figure 3.15. N-CoR loss in HCC cells might be associated with an up-regulation 
           of APR genes 
Semi-quantitative PCR analysis of selected APR genes in HCC cells. The APR genes 






Figure 3.16. Pro-inflammatory cytokine promotes degradation of N-CoR 
 




3.4.3 APR genes are not repressed by N-CoR  
 
 Next, to confirm if N-CoR was really involved in the repression of APR 
genes, we used genistein which had previously been shown to restore N-CoR in SK 
Hep1 cells (Figure 3.3) to analyse the effects of N-CoR restoration on APR gene 
expression. RT-PCR analysis of APR gene expression after genistein treatment 
revealed an up-regulation of mRNA expression levels for all the 3 APR genes in a 
dose dependent manner (Figure 3.17). This was in contrast to the hypothesized role of 
N-CoR in the repression of APR genes. Thus, we ruled out the possibility of 




             
Figure 3.17. APR genes were up-regulated in a dose dependent manner after  
           genistein treatment 
 
APR gene expression levels in SK Hep1 cells after genistein treatment was 
determined via semi-quantitative RT-PCR. 
 
 
B. N-CoR misfolding and Epithelial Mesechymal Transition (EMT) 
3.4.4   The levels of EMT gene transcripts in HCC cells are high 
 N-CoR has been implicated in the activation of phosphatidylinositol 3' kinase 
(PI3K)/AKT pathway, a central feature of epithelial-mesenchymal transition (EMT). 
Thus, we wanted to investigate if N-CoR misfolding was linked to the activation of 
EMT pathway. Four characteristic EMT genes (Slug, Twist-1, Snail and Vimentin) 
were selected and their expression levels were screened through semi-quantitative 
RT-PCR. Based on similar hypothesis as described in 3.4.1, we wanted to identify the 
genes whose expression would reflect an inverse correlation to N-CoR status. Figure 
3.18 showed that there was no distinct inverse correlation between N-CoR and the 




Figure 3.18. Expression level of EMT genes 
 
Semi-quantitative PCR analysis of selected EMT genes in N-CoR expressing HepG2 
cells and HBX positive HCC cells where N-CoR is lost. 
 
 
3.4.5 EMT genes are not repressed by N-CoR 
 
 To gain further insight if EMT may be a functional consequence of N-CoR 
loss, similar experiment as described in 3.4.3 was carried out. SK Hep1 cells were 
treated with 25µM genistein for 72 hours to restore N-CoR protein and the level of 
various EMT genes was screened via RT-PCR. This screening did not reveal any 
down-regulation of EMT genes after N-CoR restoration, indicating that none of these 
genes were possible N-CoR transcriptional targets (Figure 3.19). Hence, we 




                
Figure 3.19. N-CoR did not repress EMT gene expression after genistein  
          treatment 
EMT gene expression levels in SK Hep1 cells after genistein treatment were 
determined via semi-quantitative RT-PCR. The EMT genes were not repressed upon 
genistein treatment. 
 
C. N-CoR misfolding and Autophagy 
3.4.6 Autophagy is activated in HCC cells 
 Autophagy has recently been reported to be a cellular survival mechanism 
activated in mammalian cells in response to nutrient deprivation and stress. Several 
laboratories have also reported that autophagy could be induced by ER stress 
(Kawakami et al., 2009; Yorimitsu et al., 2006). Based on these reports, we decided 
to investigate if there was activation of autophagy in HCC cells where ER stress level 
was found to be high (Figure 3.12). The relative levels of LC3-II in the HCC cells 
were determined through western blotting analysis. LC3-II, the processed form of 
LC3, has a reported molecular weight of 14 kDa while LC3-I, the unprocessed form, 
was reported to be a 16 kDa protein. The LC3-II/LC3-I ratio was commonly used as 
an indicator for autophagy activity as reported earlier in several publications. This 
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however was debatable due to the dynamic nature of autophagic processes. Thus, a 
better approach of autophagy assessment would be to determine the expression level 
of LC3-II alone. We observed higher levels of LC3-II in majority of the HBX positive 
cell lines when compared to HepG2, suggesting a selective up-regulation of 
autophagy in HBX positive cells (Figure 3.20).           
 3.4.7 Formation of autophagosomes in HBX positive cells 
 Autophagy is also characterised by the formation of autophagosomes. The 
hallmark of autophagosomes is a punctated dot-like distribution of LC3. We then 
conducted immunofluorescence staining to check the presence of autophagosomes by 
determining the distribution of LC3 protein. Their presence in HBX positive cells was 
evidenced by the numerous small peri-nuclear punctated red signals (Figure 3.21). We 
also observed partial co-localization of N-CoR (green signals) with LC3 as indicated 
by the speckled orange-yellow signals (Figure 3.21, overlay). This incomplete 
overlapping of N-CoR with LC3 could be due to the rapid degradation of N-CoR 
protein in the autophagosomes. In contrast, the red LC3 signal was greatly diminished 
in HepG2 cells with no co-localization of N-CoR and LC3 (Figure 3.21).  
73 
 
         
Figure 3.20. Level of LC3-II in HBX positive cells is elevated 
Level of LC3 in HCC cells (upper panel) was determined through western blot with 
LC3 antibody. The higher level of LC3-II seen in the HBX positive cells indicated an 


















    
 
Figure 3.21. Autophagosomes are seen in HBX positive cells 
 
Cells were fixed and stained for endogenous N-CoR (green) and LC3 (red) with N-
CoR and LC3 antibodies respectively. DNA was stained with DAPI (blue). Co-
localization of N-CoR and LC3 was observed as orange-yellow signals in the HBX 
positive cells. There was no co-localization observed in HepG2 cells. In addition, the 
punctuated dot like pattern observed in HBX positive cells indicated the presence of 






3.4.8 Loss of N-CoR may be linked to autophagy 
 Next, to study if N-CoR was degraded via autophagy in HCC cells, we tested 
the effect of bafilomycin A1 (BA-1), a chemical inhibitor of autophagy, on N-CoR 
loss in SK Hep1 cells. Western blot data showed that BA-1 promoted stabilization of 
N-CoR at a concentration of 0.5nM, suggesting that N-CoR loss in SK Hep1 cells 
could be due to autophagy. 
                     
Figure 3.22. Bafilomycin A1 promotes stabilization of N-CoR protein in SK Hep1 
           cells 
SK Hep1 cells were treated with BA-1 for 72 hours and the level of full length N-CoR 










3.4.9 HBX activates autophagy 
 Our finding demonstrated that misfolded N-CoR could be degraded via 
autophagy (Figure 3.22). Since N-CoR misfolding is a consequence of HBX 
engagement (as discussed in the earlier sections), therefore we next investigated 
whether ectopic HBX could activate autophagy in an N-CoR dependent manner. The 
effect of HBX on autophagy was assayed by determining the level and distribution of 
LC3-II, the processed form of LC3 linked to GFP. Our western blot data revealed that 
in the presence of HBX and N-CoR, LC3-II level was slightly elevated when 
compared to its level in HeLa cells transfected with HBX alone (Figure 3.23A). 
 For immunofluorescence (IF) assay, HeLa cells were transfected in a similar 
way as above and the presence of autophagosomes was detected using fluorescence 
signals of LC3 protein (green signals). The intensity of green florescence signals 
derived from LC3 was significantly higher when cells were transfected with HBX and 
N-CoR (Figure 3.23B), suggesting an increased formation of autophagosome when N-
CoR and HBX were expressed together. In contrast, HBX or N-CoR alone failed to 
induce a similar level of autophagic response. These findings collectively suggest that 
HBX-induced misfolded N-CoR may play a role in the induction of autophagy. 
3.4.10 Autophagy supports the growth of HCC cells 
 Based on the findings presented so far, we thought that activation of 
autophagy-mediated N-CoR degradation could confer pro-survival advantage to 
tumour cells during stress and starvation. Thus, to investigate if N-CoR was involved 
in sustaining the growth and survival of HCC cells, we determined the growth and 












Figure 3.23. HBX induced activation of autophagy is mediated by misfolded N-
           CoR 
 
(A) Processing of LC3 was determined in HeLa cells transfected with GFP-LC3 
expression plasmid along with plasmids mentioned on top of each lane. LC 3-I and 
LC3-II indicated the position of unprocessed and processed (activated) forms of LC3 
protein respectively. LC3 protein was detected using the GFP antibody. Higher level 
of LC3-II was observed in HeLa cells transfected with HBX and N-CoR. (B) HeLa 
cells were transfected with the GFP-LC3 plasmid, together with the various 
combinations of plasmids as shown on the left of each row. Sub-cellular localization 
as well as intensity of LC3 (green) signal was determined using fluorescence 
microscopy. Punctuated dot like structures appeared to be more prominent in the 
presence of HBX and N-CoR. 
 
 First, efficiency of N-CoR ablation by N-CoR siRNA in SK Hep1 cells was 
confirmed by RT-PCR (Figure 3.24A). Next, the survival and growth of N-CoR 
ablated cells was compared to non-ablated cells through morphological analysis. After 
N-CoR ablation in SK Hep1 cells, there was a significant reduction of growth along 
with a noticeable increase in the number of dead cells, suggesting that N-CoR 
catabolism might be directly linked to the growth and survival of these cells (Figure 
3.24B). Next, to examine if ATP generated from the proposed N-CoR catabolism was 
involved in maintaining the growth and survival of SK Hep1, the ATP levels in these 
cells was determined before and after N-CoR knockdown. A significant reduction 
(around 50%) in the intra-cellular ATP level was observed after N-CoR ablation, 
suggesting that autophagy-mediated degradation of N-CoR could act as a source of 
ATP generation in SK Hep1 cells (Figure 3.24C).  
 
 





Figure 3.24. N-CoR loss is linked to ATP mediated growth of SK Hep1 cells 
(A) Level of N-CoR transcript in SK Hep1 cells exposed to scrambled or N-CoR 
siRNA was determined via RT-PCR. (B) The growth and survival of SK Hep1 cells 
exposed to scrambled or N-CoR siRNA was determined by morphological analysis.  
(C) Intracellular ATP level in SK Hep1 cells exposed to scrambled or N-CoR siRNA 
was determined by ATP assay. Around 50% reduction in ATP level was observed 









Chapter 4. Discussion 
 
4.1  Role of misfolded N-CoR in HCC pathogenesis 
 Misfolded N-CoR was first implicated in the pathogenesis of APL when it was 
found that PML-RARα, the fusion oncoprotein linked to transformation in APL, 
could induce N-CoR misfolding and loss through aberrant post translational 
modification. The misfolded N-CoR protein accumulated in the ER and activated 
unfolded protein response (UPR), resulting in N-CoR degradation ultimately (Khan et 
al., 2004). Based on APL data, it was essential to establish a role of misfolded N-CoR 
in other tumour as well. Since then, role of misfolded N-CoR has been established in 
several tumours such as lung and gastric cancer cells (data not shown) and HCC cells 
(Figure 3.1A). As presented in this report, we then analyzed the status of N-CoR 
protein in human liver cancers. An APL-like loss of N-CoR protein was observed in 
human primary cancer cells (Figure 3.1B), suggesting a potential pathophysiological 
role of N-CoR in the pathogenesis of liver cancer. Hence, we investigated the role of 
misfolded N-CoR based on the criteria established in APL cells.  
4.2 HBX induces a conformational change in N-CoR 
 Previously, it has been demonstrated that PML-RARα-induced aberrant post-
translational modification of N-CoR contributed to its misfolding and instability in 
APL cells (Ng et al., 2006; Khan et al., 2004). PML-RARα can trigger a 
conformational change in N-CoR by inducing its ubiquitination and phosphorylation. 
Therefore, it is likely that MCDL of N-CoR in HCC cells is an outcome of similar 
post-translational modifications triggered by a yet to be identified oncogenic 
alteration. The findings reported here strongly suggested that viral proteins like HBX 
can create a PML-RARα like effect on the conformation of N-CoR protein. A study 
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has shown that the integrity of PML oncogenic domain (POD), of which N-CoR is an 
important component, was altered in several cases of viral infections (Day et al., 
2004). Therefore, N-CoR itself seems to play an important role in the structural and 
functional integrity of POD which the oncogenic viruses like Hepatitis B virus (HBV) 
and Hepatitis C virus (HCV) must overcome to invade the cells and promote 
transformation.  
 Based on the data presented so far, it is hypothesized that HBX may disrupt 
POD structural integrity and N-CoR mediated transcriptional repression activity in 
HCC cells. The molecular mechanism underlying the oncogenic potential of HBX is 
still unclear but it is possible that cytoplasmic HBX may engage N-CoR just after 
translation in the cytosol. All in all, we hypothesized that N-CoR may have acquired 
an abnormal conformation due to this engagement by HBX. 
4.3 HBX-induced conformational change leads to instability and N-CoR 
 protein degradation 
 
 There are protein quality control mechanisms in the cell which are activated to 
deal with the consequence of protein misfolding. The first effect of accumulation of 
misfolded proteins is the activation of unfolded protein response (UPR) which 
activates chaperones to correct misfolding. However, if misfolded proteins fail to be 
corrected, they will be removed through the ubiquitin proteosome pathway (UPP). 
Most misfolded proteins that are cleared via the UPP tend to be ubiquitinated. 
Consistent with this notion, misfolded N-CoR appears to be highly ubiquitinated 
(Figure 3.10B, 3.11B), suggesting that misfolded N-CoR might be a target of the 
UPP. Based on this data, we hypothesized that the ubiquitination observed in HCC is 
a form of post translational modification (PTM) that tags misfolded N-CoR, so that it 
will be recognized by the proteasome for degradation. This then raises the question of 
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how misfolded N-CoR is ubiquitinated. It was hypothesized in APL that PML-RARα 
functioned as E3 ligases in N-CoR ubiquitination (Khan et al., 2004). The exact role 
of HBX underlying the ubiquitination of N-CoR protein remains unclear but based on 
the hypothesis in APL and our preliminary findings (Figure 3.10B, 3.11B); we 
speculated that HBX, like PML-RARα, could have function as an E3 ligase. 
 Although misfolded N-CoR is highly ubiquitinated, it may not be entirely 
degraded by UPP since MG132 treatment did not result in complete N-CoR 
stabilization (Figure 3.10A, 3.11A). It could be possible that the proteasome function 
is inhibited by the misfolded protein itself thus preventing its effective removal. There 
is also evidence that complete removal of misfolded proteins by UPP is not achieved 
due to a direct inhibitory effect of misfolded proteins on UPP. For example, this 
situation  has  been  reported  in  Parkinson’s  disease  whereby  the  toxic  accumulation  of  
abnormal proteins (Lewy bodies) inhibited the function of UPP. This led us to 
speculate that misfolded proteins may be ubiquitinated but not necessarily degraded 
by the proteasome under pathological conditions. So under this stressful condition 
whereby degradation might be impaired, how do tumour cells remove these 
aggregated proteins? 
4.4 Role of autophagy in the survival and growth of HCC cells  
 Degradation of misfolded N-CoR has been implicated to be an outcome of 
autophagic response (Figure 3.22) in HCC cells. Reports of autophagy being involved 
in the removal of misfolded proteins and in the alleviation of ER stress to non-
cytotoxic levels have also been described in Huntington disease (Ravikumar et al., 
2002),  Alzheimer’s  disease  (Boland  et al., 2008) and Parkinson disease (Dice, 2007). 
Therefore, it is likely that in situations whereby the proteasome is overwhelmed with 
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a deleterious level of misfolded proteins, autophagy might be activated to remove the 
excess misfolded protein load. This degradation serves as a way to offset the toxic 
insult of misfolded proteins, allowing tumour cells to gain survival advantage. In 
addition, autophagy has been reported to promote catabolic reactions to satisfy the 
energy requirements of cells for maintenance and protein synthesis by recycling 
metabolites under stress conditions (Kadowaki et al., 2006; Levine and Kroemer, 
2008). Therefore, other than protecting cells by clearing the misfolded protein load, 
we hypothesized that autophagy-mediated degradation of N-CoR can also sustain the 
growth of HCC cells by recycling the N-CoR end products into ATP. The inhibition 
of cell growth (Figure 3.24B) and ATP level reduction (Figure 3.24C) after N-CoR 
ablation suggested that this hypothesis may be true. 
 
4.5 Role of HBX-induced misfolded N-CoR in the activation of UPR and  
            autophagy 
 
 We think that accumulation of HBX-induced misfolded N-CoR protein in the 
ER of normal hepatic cells induces ER stress which ultimately leads to UPR-induced 
apoptosis. This phenomenon is known as cytotoxic UPR. Indeed, we observed a 
shrinkage/condensation of nucleus in HBX transfected 293T cells (refer to arrows in 
Figure 3.5) which are indicative signs of cell death. Supposingly, this should 
eliminate the possibility of tumour formation. So, how do the tumours arise if the 
HBX infected hepatocytes are killed due to ER stress?  
 Based on our findings and the APL model, we proposed a novel component of 
UPR (cytoprotective UPR) that might induce transformation in cancer cells. We 
hypothesized that in HCC cells, a bulk of misfolded N-CoR protein (induced by 
HBX) will first be transported to the ER and degraded via the UPP (Figure 3.10, 
3.11). The degradation helps HCC cells to survive the initial cytotoxic effects of UPR 
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and may possibly be the precursor for transformation. Subsequently under prolonged 
ER stress induced by the misfolded proteins whereby proteasomal-mediated 
degradation becomes defective, misfolded proteins may be targeted to the autophagic 
vacuoles for further removal (Figure 3.20, 3.21). Since autophagy supports cell 
growth and survival, a clonal growth advantage will be conferred to each transformed 
cell that ultimately forms the tumour bulk.  
 In conclusion, we hypothesized that accumulation of misfolded N-CoR protein 
probably triggers synergistic actions on the proteasome and autophagy, thereby 
contributing to the survival of HCC cells through neutralization of ER stress and 
protection from UPR-induced apoptosis. At the same time, growth of HCC cells in a 
stressful and nutrient depleted condition is sustained by ATP generated from the 
autophagy induced degradation of misfolded N-CoR protein. A schematic model for 
the role of HBX-induced misfolded N-CoR protein in the survival and growth of HCC 
cells is presented (Figure 4.1). This model highlights the multiple connections 
between mechanisms behind N-CoR loss, resistance to UPR-induced apoptosis and 

































 Figure 4.1. Schematic representation of the regulation of UPR and autophagy in 
        normal and HCC cells. 
A. In normal hepatic cells, accumulation of HBX-induced misfolded N-CoR protein      
in the ER will stimulate ER stress which would ultimately lead to UPR-induced 
apoptosis, thus eliminating the possibility of transformation. 
 
B. In HCC cells, however, toxicity associated with misfolded HBX-N-CoR will 
initially be neutralized due to the ubiquitin-proteasome mediated degradation of 
misfolded N-CoR protein. With further accumulation of misfolded proteins, 
autophagy is activated and assists in the clearance of misfolded proteins. This results 
in reduction of ER stress and eventual protection of HCC cells from UPR-induced 
apoptosis. HBX containing cells remain viable and with the help of autophagy in 







4.6 Future areas of research 
 
4.6.1 Mechanism of autophagy mediated N-CoR loss in liver cancer 
 pathogenesis 
 
 Our recent data suggest that autophagy could be the major pathological 
mechanism in liver malignancy. Nevertheless, there is a need to interpret this data 
with care and more experiments should be done to verify the hypothesis. The 
induction of autophagy could be verified further with p62, a widely used autophagy 
marker (Bjørkøy et al., 2009). Also, given that an increase in autophagy would bring 
about a parallel increase in lysosomal proton pumping and lysosomal acidity, an 
acidotropic dye, for example, acridine orange could be used for staining lysosomes 
based on pH (Paglin et al., 2001; Kanzawa et al., 2003). In addition, the presence of 
autophagosomes should be further confirmed using advanced techniques like electron 
microscopy (Dunn, 1990). All in all, there appears to be a gap in knowledge between 
how the misfolded protein from the initiation of UPR contributes to the subsequent 
malignant growth in HCC cells. More work is required to establish this link.   
  
4.6.2 Identification of misfolded N-CoR as a molecular target in HCC 
 The ultimate goal of this study is to discover potential therapeutic targets to 
improve cancer therapy. The limitation in the development of safe and effective 
anticancer drugs and devices lies in our inability to selectively kill cancer cells with 
agents or process which will have minimum effect on normal cells. Unfortunately, 
despite significant progress in our understanding about the mechanisms underlying 
malignant growth and transformation of tumour cells, we still do not have a precise 
understanding of the difference between a cancer cell and its normal counterpart. 
During the past decade, efforts to characterize that difference was mostly focused on 
identifying cell surface markers that are uniquely present only on cancer cells. 
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 However, despite the intense search, only a handful of antigens have been 
identified so far that are specifically associated with a particular type of cancer cell. 
The outer membrane of a cancer cell may not always have a well defined signature 
that could distinguish it from a normal cell, however, somewhere among the 
thousands of macromolecules packed within each cancer cell are one or more proteins 
which bear the footprints of the fateful events that led the cell on the path of 
transformation.   
 Therefore, to a large extent, identification and characterization of these protein 
conformation based oncogenic hallmarks within an intact cancer cell will not only 
enable us to detect the earliest sign of disease event, but will also help in creating 
highly selective therapeutic tools. Protein products of oncogenes and tumour 
suppressor genes, as well as proteins whose structures and functions are affected due 
to direct or indirect association with these proteins may represent the best possible 
intracellular signature for selective targeting of cancer cells.  
 Identification and characterization of conformational defect of N-CoR protein 
in HCC may possibly be useful in the development of novel conformation based 
therapeutic agents. Previously, a role of genistein as a potent inhibitor of N-CoR 
misfolding has been demonstrated in APL (Ng et al., 2007). Interestingly, we found 
out that genistein could promote stabilization of N-CoR protein in HBX positive SK 
Hep1 cells (Figure 3.3). Genistein works by correcting the conformation of N-CoR 
protein and thus restores its tumour suppressive functions. We have also showed that 
MG132 (proteasome inhibitor) and BA-1 (autophagy inhibitor) could promote 
stabilization of N-CoR protein in HCC cells (Figure 3.11A, 3.22). Since degradation 
of misfolded N-CoR might confer stress tolerance and protect cells from ER stress-
induced apoptosis, hence, by inhibiting N-CoR degradation, this escape route will be 
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blocked and tumour cells will be re-sensitized to ER stress-induced apoptosis. As 
such, there will not be malignant transformation. Encouraged by this, we intend to test 
the pro-apoptotic effect of a clinical grade proteasome inhibitor, bortizomib in HCC 
cells. All in all, investigation on the mechanisms behind N-CoR misfolding/loss 
provides useful information for therapeutic purposes.  
 
4.6.3 Appropriate experimental controls 
 By and large, the data obtained so far is undoubtedly incomplete and 
fragmented. One critical issue in this study is the unavailability of reliable and 
positive controls. Two different types of cell lines (HepG2 and HBX positive HCC 
cells) with differing HBX and N-CoR properties were used in this study. Although 
HepG2 is HBX negative and harbours intact N-CoR protein, it is not an appropriate 
control because of its inherent tumourigenic properties. This probably explains for the 
inconsistencies that we have observed in our experiments. For example, we did not 
expect to detect a high level of GRP78 in HepG2 (Figure 3.12C). Thus, it is 
imperative to obtain and include normal liver cell lines and human tissues in all 
experiments. This should help to yield more clues and aid in the validation of the 
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